STOCK TITAN

Liberty Defense issues Q3 2026 going-concern warning

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Liberty Defense Holdings, Ltd. (DETX) reported third-quarter 2026 revenue of $720,717, compared with $279,049 in the 2025 quarter, including $637,958 of HEXWAVE revenue. For the nine months ended September 30, 2026, revenue was $1,682,339 versus $1,764,256, and net loss narrowed to $7,898,603 from $10,510,206.

Cash used in operating activities was $11,227,106 for the nine months, compared with $8,379,896 in 2025. At September 30, 2026, cash was $3,720,790 and current liabilities were $2,986,985. Net cash provided by financing activities was $14,776,656. Liberty repaid its Viken balance and Parabilis term loan and credit line; each balance was $nil at period end.

Management said operations depended on additional financing and sufficient cash flows from operations. No definitive financing arrangements had been secured as of November 12, 2026, and management stated that substantial doubt exists about the company’s ability to continue as a going concern.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 2 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue rose to $720,717 from $279,049.
  • Moderate pointNine-month net loss narrowed to $7,898,603 from $10,510,206.

Negative

  • Major pointOperating cash outflow reached $11,227,106, versus $8,379,896.
  • Major pointLiberty disclosed substantial doubt about continuing as a going concern.

Filing Explained

Liberty’s April 23 IPO issued 770,807 pre-funded warrants for $3,468,554; each was immediately exercisable for one share at $0.0001, with no expiry. If exercised, they add shares to the 5,681,983 common shares reported at September 30, reducing existing holders’ percentage ownership absent offsetting changes.

Third-quarter revenue $720,717 Three months ended September 30, 2026; $279,049 in the 2025 quarter
HEXWAVE revenue $637,958 Three months ended September 30, 2026
Nine-month revenue $1,682,339 Nine months ended September 30, 2026; $1,764,256 in 2025
Nine-month net loss $7,898,603 Nine months ended September 30, 2026; $10,510,206 in 2025
Cash used in operating activities $11,227,106 Nine months ended September 30, 2026; $8,379,896 in 2025
Cash $3,720,790 As of September 30, 2026; $319,294 as of December 31, 2025
Current liabilities $2,986,985 As of September 30, 2026; $8,616,300 as of December 31, 2025
Cash provided by financing activities $14,776,656 Nine months ended September 30, 2026
going concern financial
"substantial doubt exists about the Company's ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
bill-and-hold revenue recognition financial
"Revenue from bill-and-hold arrangements is recognized when control of the product is transferred"
derivative warrant liability financial
"Derivative warrant liabilities are measured at fair value at each reporting date"
A derivative warrant liability is an obligation recorded on a company’s balance sheet when it has issued warrants (option-like contracts) that may require the company to deliver cash or shares in the future. Like a promise to repay or hand over something under certain conditions, it matters to investors because it can dilute existing shareholders if warrants are converted into stock, create future cash outflows, and change a company’s reported financial strength — similar to a pending bill or coupon on a bond.
functional currency financial
"changed its functional currency from the Canadian dollar to the U.S. dollar"
The functional currency is the single currency a company uses as its primary money for recording business transactions and preparing financial statements — think of it as the company's "home" currency or the money it budgets and measures performance in. It matters to investors because currency choices determine how foreign sales, costs and exchange-rate swings translate into reported revenue, profit and debt, affecting comparisons, risk assessments and valuation.
pre-funded warrants financial
"pre-funded warrants issued in connection with the Company's initial public offering"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did DETX report in Q3 2026?

DETX reported $720,717 in total revenue for the three months ended September 30, 2026, compared with $279,049 in the 2025 quarter. HEXWAVE revenue was $637,958, and contract revenue was $82,759.

What happened to Liberty Defense’s TSA HD-AIT Phase II B contract revenue?

Liberty recognized $357,759 of contract revenue for the nine months ended September 30, 2026. It said all contract revenue had been completed as of September 30, with no additional revenue expected currently.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of: November, 2026

 

Commission File Number: 001-43241

 

Liberty Defense Holdings, Ltd. 

 

(Translation of registrant’s name into English)

 

187 Ballardvale Street, Suite 110, Wilmington, Massachusetts 01887 

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x  Form 40-F ¨

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit    Description
99.1   Condensed Interim Consolidated Financial Statements (Unaudited) for the Three Months and Nine Months Ended September 30, 2026 and 2025
99.2   Management’s Discussion and Analysis for the Three Months and Nine Months Ended September 30, 2026
99.3   Form 52-109FV2 Certification of Interim Filings of CEO for the Interim Period Ended September 30, 2026
99.4   Form 52-109FV2 Certification of Interim Filings of CFO for the Interim Period Ended September 30, 2026

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 16, 2026

 

  LIBERTY DEFENSE HOLDINGS, LTD.
     
     
  By: /s/ Keith Teichmann
  Name: Keith Teichmann
  Title: Interim Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

Liberty Defense Holdings, Ltd.

 

Condensed Interim Consolidated Financial Statements

(Unaudited)

 

For the Three and Nine Months Ended September 30, 2026 and 2025

 

Prepared by Management

 

(Expressed in U.S. dollars)

 

 

 

 

 

LIBERTY DEFENSE HOLDINGS, LTD.

 

Responsibility For Unaudited Condensed Interim Consolidated Financial Statements

For the Three and Nine Months Ended September 30, 2026 and 2025

 

The accompanying unaudited condensed interim consolidated financial statements of Liberty Defense Holdings, LTD. and all information in this financial report are the responsibility of the Board of Directors and Management. The interim unaudited condensed consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), including International Accounting Standard (“IAS”) 34 – Interim Financial Reporting and, where appropriate, include management’s best estimates an judgements. Management maintains a system of internal control designed to provide reasonable assurance that assets are safeguarded from loss or unauthorized use, and that financial information is timely and reliable. However, any system of internal control over financial reporting, no matter how well designed and implemented, has inherent limitations and may not prevent or detect all misstatements. The Board of Directors is responsible for reviewing and approving the unaudited condensed interim consolidated financial statements. The Board of Directors carries out this responsibility principally though its Audit Committee. The Board of Directors appoints the Audit Committee, and all of its members are independent directors. The Audit Committee meets periodically with Management and the auditors to review internal controls, audit results, accounting principles and related matters. The Board of Directors approves the unaudited condensed interim consolidated financial statements on recommendation form the Audit Committee.

 

"Keith Teichmann" "Omar Garcia Abrego"
Chief Executive Officer Chief Financial Officer
 
November 12, 2026

 

 

 

 

Liberty Defense Holdings, Ltd.

Condensed Interim Consolidated Statements of Financial Position

(Unaudited - Expressed in U.S. dollars)

 

As at:  Note  September 30
2026
   December 31,
2025
 
        $      $  
Assets             
Current assets:             
Cash      3,720,790    319,294 
Accounts receivable, prepaids and deposits  4   1,808,807    1,248,367 
Inventory  6   1,801,488    1,189,910 
Contract costs  18   –    152,421 
Deferred financing costs      –    803,698 
       7,331,085    3,713,690 
Non-current assets:             
Property and equipment  7   452,731    671,793 
Intangible assets  8   1,569,680    1,999,132 
Available             
       2,022,411    2,670,925 
              
Total assets      9,353,496    6,384,615 
              
Liabilities             
Current liabilities:             
Accounts payable and accrued liabilities  5 & 20   2,415,851    4,882,377 
Parabilis term-loan  10   –    2,622,717 
Factoring and credit line liability  11   –    779,831 
Deferred revenue  17   325,745    95,541 
Lease liabilities  12   245,389    235,834 
       2,986,985    8,616,300 
Non-current liabilities:             
Non-current lease liabilities  12   108,173    300,401 
Derivative warrant liability  15   25,018    – 
Total liabilities      3,120,176    8,916,701 
              
Shareholders’ equity (deficiency)             
Share capital  13   64,891,151    51,355,559 
Equity reserves  14   7,972,015    6,390,580 
Accumulated other comprehensive income      200,339    179,164 
Deficit      (66,830,185)   (60,457,389)
Total shareholders’ equity (deficiency)      6,233,320    (2,532,086)
              
Total liabilities and shareholders’ equity (deficiency)      9,353,496    6,384,615 

 

Nature of operations and going concern (note 1)

Subsequent events (note 25)

 

Approved on behalf of the Board of Directors:

 

"John Percival" "Will Hamilton"
Director Director

 

The accompanying notes form an integral part of these condensed interim consolidated financial statements.

 

 

 

 

Liberty Defense Holdings, Ltd.

Condensed Interim Consolidated Statements of Loss and Comprehensive Loss

(Unaudited - Expressed in U.S. dollars, except share and per share amounts)

 

    Three months ended September 30,   Nine months ended September 30, 
  Note  2026   2025   2026   2025 
                 $      $  
Revenue 17 & 18                    
HEXWAVE revenue     637,958    129,049    1,324,580    909,407 
Contract revenue     82,759    150,000    357,759    854,849 
Total Revenue     720,717    279,049    1,682,339    1,764,256 
                       
Cost of revenue                      
HEXWAVE cost of revenue     821,248    838,101    2,401,872    2,112,884 
Contract cost of revenue     324,522    394,939    851,124    1,493,636 
Total cost of revenue     1,145,770    1,233,040    3,252,996    3,606,520 
Gross loss     (425,053)   (953,991)   (1,570,657)   (1,842,264)
                       
Engineering and Research and Development Expenses:     1,166,284    668,780    2,859,198    2,058,666 
Product development & technology Costs     178,029    79,417    373,301    263,754 
Salaries and consulting fees 20   550,420    522,163    1,516,035    1,542,588 
Stock-based compensation 14 & 20   -    134    -    15,240 
Depreciation 7   110,779    57,300    311,942    189,809 
Office, rent & administration, travel, and miscellaneous     327,056    9,766    657,920    47,275 
                       
General & Administration Expenses                      
Salaries and consulting fees 20   817,165    273,845    1,495,010    1,287,457 
Legal and professional fees     131,571    80,693    712,400    769,076 
Stock-based compensation 14 & 20   131,332    122,412    474,370    1,099,231 
General, administrative and corporate expenses     438,518    719,821    2,053,759    2,945,674 
      2,684,870    1,865,551    7,594,737    8,160,104 
                       
Operating Loss    $(3,109,923)  $(2,819,542)   (9,165,394)   (10,002,368)
                       
Other (income) expense:                      
Other income, net     (10,152)   (3,341)   (128,309)   (4,671)
Gain on initial recognition of warrant liability 15   199,505    -    (1,130,876)   - 
Gain on fair value change in warrant liability 15   (371,924)   -    (451,372)   - 
Loss on debt settlement     -    -    29,995    - 
Interest expense 9 & 10   33,649    142,966    404,901    483,898 
Foreign exchange (gain) loss     9,186    8,597    8,870    28,611 
      (139,736)   148,222    (1,266,791)   507,838 
                       
Net loss for the period    $(2,970,187)  $(2,967,764)   (7,898,603)   (10,510,206)
                       
Other comprehensive loss                      
Items that may be reclassified subsequently to profit or (loss)                      
Foreign currency translation adjustment     -    (129,790)   -    112,660 
Total loss and comprehensive loss for the period    $(2,970,187)  $(3,097,554)   (7,898,603)   (10,397,546)
                       
Weighted average number of common shares outstanding                      
Basic and diluted     6,446,907    1,459,462    4,606,982    1,234,756 
Loss per share                      
Basic and diluted loss per common share 16   (0.46)   (2.03)   (1.71)   (8.51)

 

The accompanying notes form an integral part of these condensed interim consolidated financial statements.    

 

 

 

 

Liberty Defense Holdings, Ltd.

Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficiency)

(Unaudited - Expressed in U.S. dollars, except share and per share amounts)

 

    Number of         Accumulated
other
       
     common   Share   Equity   comprehensive         
  Note  shares   capital   reserves   income (loss)   Deficit   Total 
       #      $      $      $      $      $  
Balance as at December 31, 2024     962,919    40,717,157    4,872,472    (28,896)   (46,325,212)   (764,479)
                                 
Issue of private placement, net of share issue cost 13   511,800    6,120,797    –    –    –    6,120,797 
Residual value allocated to warrants 14   –    (263,584)   263,584              – 
Fair value of broker warrants allocated to share capital 13   –    (129,091)   129,091    –    –    – 
Warrants exercised for cash 13   120,395    2,075,555    –    –    –    2,075,555 
Restricted share units issued 13   4,536    374,067    (374,067)   –    –    – 
Stock based compensation 13   –    –    1,135,285    –    –    1,135,285 
Foreign currency translation adjustment 13   –    –    –    112,660    –    112,660 
Loss for the period     –    –    –    –    (10,510,206)   (10,510,206)
                                 
Balance as at September 30, 2025     1,599,650    48,894,901    6,026,365    83,764    (56,835,418)   (1,830,388)
                                 
Issue of private placement and initial public offering net of share issue cost 13   3,761,264    14,847,516    2,994,501    –    –    17,842,017 
Warrants exercised 12             –    –    –    – 
Residual value allocated to warrants 14   –    (56,452)   56,452    –    –    – 
Restricted shares units exercised 13   736    59,797    (59,797)   –    –    – 
Shares issued on debt settlement 13   23,306    82,485    –              82,485 
Fair value of broker warrants allocated to share capital 13   –    (13,087)   13,087    –    –    – 
Fair value of warrants allocated to share capital on expiry 14   –    45,209    (45,209)             – 
Stock based compensation 13   –    –    494,827    –    –    494,827 
Reclassification of warrants to derivative financial liability 15   –    –    (1,607,266)   –    –    (1,607,266)
Loss for the period     –    –    –    –    (7,898,603)   (7,898,603)
Foreign exchange impact from change in functional currency 2   –    (1,429,876)   (265,160)   21,175    1,525,807    (148,054)
                                 
Balance as at September 30, 2026     5,681,983    64,891,151    7,972,015.00    200,339    (66,830,185)   6,233,320 

 

The accompanying notes form an integral part of these condensed interim consolidated financial statements.

 

 

 

 

Liberty Defense Holdings, Ltd.

Condensed Interim Consolidated Statements of Cash Flows

(Unaudited - Expressed in U.S. dollars)

 

     Nine Months Ended September 30, 
   Note  2026   2025 
       $    $  
Cash (used in) provided by:             
              
Operating activities:             
Loss and comprehensive loss for the period      (7,898,603)   (10,510,206)
Items not involving cash:             
Lease liability interest  12   35,879    32,697 
Accrued interest  9   143,404    253,856 
Depreciation  7   309,062    197,214 
Amortization recorded in cost of revenue  8   429,452    381,711 
Loss on disposal of lease  12   –    (18,514)
Stock based compensation  14   494,827    1,135,285 
Impairment of inventory  6   149,919    233,676 
Credit line Parabilis interest and fees  11   104,555    304,554 
Warrant liability initial recognition  15   (1,130,876)   – 
Warrant liability revaluation  15   (451,372)   – 
Changes in non-cash working capital  19   (3,413,353)   (390,169)
Cash used in operating activities      (11,227,106)   (8,379,896)
              
Investing activities:             
Additions to property and equipment  7   –    (176,498)
Cash used in investing activities      –    (176,498)
              
Financing activities:             
Proceeds from equity issuance, net of share issue costs  13   18,645,715    6,120,797 
Repayment of working capital loans - Related Parties  9   –    (74,658)
Proceeds from working capital loans  9   327,046    – 
Repayments from working capital loans  9   (327,046)   (26,250)
Proceeds from Parabilis Term Loan  9   –    650,000 
Proceeds from factoring and credit line  11   2,754,192    350,000 
Repayments on factoring and credit line  11   (3,638,578)   (840,250)
Repayments on Parabilis Term Loan  10   (2,766,121)   (183,017)
Proceeds from warrants exercised  13   –    2,075,555 
Repayment of leases liabilities  12   (218,552)   (140,765)
Cash provided by financing activities      14,776,656    7,931,412 
              
Effect of foreign exchange rate changes on cash      (148,054)   112,660 
Effect of foreign exchange rate changes on cash      (148,054)   112,660 
              
Increase (Decrease) in cash      3,401,496    (512,322)
              
Cash, beginning of the period      319,294    1,153,229 
              
Cash, end of the period      3,720,790    640,907 

 

During the nine months ended September 30, 2026 and 2025, the Company paid $nil and $nil in income taxes, and paid $404,901 and $483,898 in interest respectively.

 

The accompanying notes form an integral part of these condensed interim consolidated financial statements.    

 

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

1.Nature of operations and going concern

 

Liberty Defense Holdings, Ltd. (“Liberty” or the “Company”) is a publicly traded company listed on NASDAQ (NASDAQ: DETX), the TSX Venture Exchange (TSXV: SCAN), the Frankfurt Stock Exchange (Frankfurt: L2D), and the OTCQB (OTCQB: LDDFF). The Company was incorporated under the Business Corporations Act (Ontario) on June 8, 2012. On July 27, 2020, Liberty continued its jurisdiction of incorporation from Ontario to British Columbia and is now governed by the Business Corporations Act (British Columbia).

 

The Company’s registered and records office is located at 1055 West Georgia Street, Suite 1500, Royal Centre, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada. Its head office is located at 187 Ballardvale Street, Suite 110, Wilmington, Massachusetts, 01887, USA.

 

The Company is engaged in the development and commercialization of advanced security detection technologies. Liberty’s flagship product, HEXWAVE, utilizes millimeter wave technology and advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the Company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning.

 

Going concern

 

These unaudited condensed interim consolidated financial statements have been prepared using IFRS Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board applicable to a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business.

 

During the nine months ended September 30, 2026, the Company incurred a net loss of $7,898,603 and had cash outflows from operating activities of $11,227,106. Given the current stage of operations and ongoing working capital requirements, its ability to continue as a going concern is dependent upon obtaining additional financing and generating sufficient cash flows from operations.

 

Management continues to evaluate financing alternatives, including potential debt and equity financing arrangements, to support the Company's operations and working capital requirements. Although the Company is actively pursuing additional financing, no definitive financing arrangements have been secured as of the date of these financial statements. While the Company has been successful in arranging financing in the past, there can be no assurance that additional financing will be available when required or on terms acceptable to the Company.

 

These events and conditions indicate that substantial doubt exists about the Company’s ability to continue as a going concern.

 

These unaudited condensed interim consolidated financial statements do not include any adjustments to the carrying amounts and classifications of assets and liabilities that would be necessary if the Company were unable to continue as a going concern. Such adjustments could be material.

 

2.Basis of presentation

 

(a)Statement of compliance

 

These unaudited condensed interim consolidated financial statements have been prepared in conformity with International Accounting Standard (“IAS”) 34, Interim Financial Reporting, using the same accounting policy information as detailed in the Company’s audited annual consolidated financial statements for the year ended December 31, 2025, unless otherwise presented below, and do not include all the information required for full annual financial statements in accordance with IFRS Accounting Standards (“IFRS”), as issued by the International Accounting Standards Board ("IASB"). It is suggested that these financial statements be read in conjunction with the annual audited consolidated financial statements.

 

1

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

2.Basis of presentation (continued)

 

(a)Statement of compliance (continued)

 

These condensed interim consolidated financial statements were approved for issuance by the Board of Directors on November 12, 2026.

 

(b)Basis of measurement

 

These condensed interim consolidated financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair value. In addition, these consolidated financial statements have been prepared using the accrual basis of accounting, except for cash flow information.

 

(c)Functional and presentation currency

 

Effective April 23, 2026, the parent company changed its functional currency from the Canadian dollar ("CAD") to the U.S. dollar ("USD"). Management determined that, following the completion of the Company's initial public offering and NASDAQ listing on April 23, 2026, the USD became the currency of the primary economic environment in which the Company operates. The change in functional currency was accounted for prospectively from the date of the change in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates.

 

The presentation currency of these condensed interim consolidated financial statements is the USD. Accordingly, references to "$" or "USD" are to U.S. dollars and references to "CAD$" are to Canadian dollars.

 

(d)Basis of consolidation

 

These condensed interim consolidated financial statements include the financial statements of Liberty Defense Holdings, Ltd., and the entities controlled by the Company (its subsidiaries), as follows:

 

Subsidiary  Place of
Incorporation
  Functional
Currency
  Beneficial
Interest
 
Liberty Defense Technologies, Inc. (“LDT”)  United States  USD  100%
LDH GS Amalco Corp. (“LDH”)  Canada  CAD  100%
DrawDown Detection, Inc. (“DDD”)  Canada  CAD  100%
DrawDown Technologies, Inc. (“DDT”)  United States  CAD  100%

 

Control exists when the Company has power over an investee, exposure, or rights, to variable returns from its involvement with the investee and the ability to use its power over the investee to affect the amount of the Company’s returns. All intercompany balances and transactions have been eliminated upon consolidation.

 

(e)Critical accounting estimates and judgments

 

The preparation of financial statements in conformity with IFRS, requires management to select accounting policies and make estimates and judgments that may have a significant impact on the consolidated financial statements. Estimates are continuously evaluated and are based on management’s experience and expectations of future events that are believed to be reasonable under the circumstances. Actual outcomes may differ from these estimates.

 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

 

2

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

2.Basis of presentation (continued)

 

(e)Critical accounting estimates and judgments (continued)

 

The Company’s critical accounting judgements and estimates were presented in Note 2 of the annual audited consolidated financial statements and have been consistently applied in the preparation of these condensed interim consolidated financial statements, except for the judgments and estimates associated with the change in functional currency and the classification and fair value measurement of certain derivative warrant liabilities, and the recognition and measurement of bill-and-hold revenue arrangements as disclosed in Notes 2(c), 3, 15 and 17.

 

3.Material Accounting Policy Information

 

These condensed interim consolidated financial statements do not include all note disclosures required by IFRS for annual financial statements and, therefore, should be read in conjunction with the audited financial statements for the year ended December 31, 2025. In the opinion of management, all adjustments considered necessary for fair presentation of the Company’s financial position, results of operations and cash flows have been included. Operating results for the nine months ended September 30, 2026, are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.

 

Change in Functional Currency

 

Effective April 23, 2026, the parent company changed its functional currency from CAD to USD as a result of changes in the underlying transactions, events and conditions relevant to the Company. In accordance with IAS 21, the change was applied prospectively from the date of the change. On April 23, 2026, all assets, liabilities and equity balances were translated into USD using the exchange rate in effect on that date, and those translated amounts became the historical carrying amounts in the Company's new functional currency. The change in functional currency did not result in the recognition of a cumulative translation adjustment.

 

Derivative Financial Liabilities

 

Derivative financial liabilities are initially recognized at fair value and subsequently measured at fair value through profit or loss at each reporting date.

 

Bill-and-Hold Revenue Recognition

 

Revenue from bill-and-hold arrangements is recognized when control of the product is transferred to the customer, even though physical possession has not yet been passed on to the customer. The Company assesses whether the criteria for recognition of revenue under a bill-and-hold arrangement have been met in accordance with IFRS 15.

 

Revenue is recognized only when all the following conditions are satisfied:

 

·The reason for the bill-and-hold arrangement is substantive and has been requested by the customer;

·The product has been separately identified as belonging to the customer;

·The product is ready for physical transfer to the customer; and

·The Company does not have the ability to use the product or direct it to another customer.

 

In evaluating whether control has transferred to the customer, the Company considers all relevant facts and circumstances, including the customer’s commitment to purchase the product, the transfer of legal title and significant risks and rewards of ownership, the customer’s acceptance of the product, and the Company’s right to payment. Where these criteria are met, revenue is recognized upon transfer of control, and any remaining obligations, such as storage or custodial services, are assessed to determine whether they represent separate performance obligations. Any consideration allocated to such services is recognized over the period in which the services are provided.

 

3

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

3.Material Accounting Policy Information (continued)

 

Bill-and-Hold Revenue Recognition (continued)

 

The assessment of whether the criteria for bill-and-hold revenue recognition have been met requires the use of significant judgment, particularly in determining when control of the product has been transferred to the customer.

 

New and Amended Accounting Standards Adopted

 

Effective January 1, 2026, the Company adopted amendments to IFRS 9, Financial Instruments, and IFRS 7, Financial Instruments: Disclosures, relating to the classification and measurement of financial instruments, as well as Annual Improvements to IFRS Accounting Standards - Volume 11. The adoption of these amendments did not have a material impact on the Company's condensed interim consolidated financial statements.

 

Accounting Standards Issued but Not Yet Effective

 

In April 2024, the International Accounting Standards Board issued IFRS 18, Presentation and Disclosure in Financial Statements, which will replace IAS 1, Presentation of Financial Statements. IFRS 18 introduces new requirements for the presentation and disclosure of financial information, including defined subtotals in the statement of profit or loss, requirements for the aggregation and disaggregation of financial information, and disclosures relating to management-defined performance measures.

 

IFRS 18 is effective for annual reporting periods beginning on or after January 1, 2027, with retrospective application required. The Company has not early adopted the standard and is currently assessing its impact on the presentation and disclosures in its consolidated financial statements.

 

4.Accounts Receivable, Prepaids and Deposits

 

   September 30,
2026
   December 31,
2025
 
Trade accounts receivables  $720,710   $470,263 
Other accounts receivables   2,830    114,980 
Prepaids and deposits   1,085,267    663,124 
   $1,808,807   $1,248,367 

 

The Company provides credit to its customers in the normal course of business and has mitigated this risk by managing and monitoring the underlying business relationships. The Company recognized $nil in expected credit losses during the nine months ended September 30, 2026 (December 31, 2025 - $13,910).

 

5.Accounts Payable

 

   September 30,
2026
   December 31,
2025
 
Accounts payable  $899,524   $2,546,832 
Accrued liabilities   1,516,327    2,335,545 
   $2,415,851   $4,882,377 

 

4

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

5.Accounts Payable (continued)

 

Accounts payable of the Company relates to amounts owed to suppliers for goods and services, as well as vendors in relation to legal services, consulting, and credit cards payable. Accrued liabilities of the Company are principally comprised of amounts professional fees, payroll-related obligations, professional fees, royalties, warranty provision, and other expenses incurred but not yet invoiced as of the reporting date.

 

Amounts payable to Viken were originally due within 120 days and bore interest at a rate of 1.5% per month on overdue balances. As at September 30, 2026, the amount payable to Viken was $nil (December 31, 2025 – $510,000). On March 19, 2026, the parties entered into an amendment requiring the Company to repay the outstanding balance on the earlier of the date the Company’s common shares commenced trading on the Nasdaq Stock Market and March 31, 2026. The amendment also resulted in the recognition of $93,379 of interest expense, increasing the total amount payable to $603,379. The Company subsequently repaid the outstanding balance in full during the nine months ended September 30, 2026, without incurring any additional penalties or charges.

 

6.Inventory

 

   September 30,
2026
   December 31,
2025
 
Raw materials  $1,141,762   $532,604 
Work-in-progress   271,855    283,656 
Finished Goods   256,800    124,550 
Right of return on finished goods   131,071    249,100 
   $1,801,488   $1,189,910 

 

During the nine months ended September 30, 2026, the Company recognized an impairment expense of $149,919 (September 30, 2025 - $233,676).

 

During the nine months ended September 30, 2026, the Company expensed $1,229,353 of inventory to HEXWAVE cost of revenue (September 30, 2025, $1,128,318).

 

During the nine months ending September 30, 2026, the Company recognized $149,795 of warranty provision expense to HEXWAVE cost of revenue (September 30, 2025, $85,894).

 

During the nine months ending September 30, 2026, the Company recorded $148,866 of amortization capitalized to inventory (September 30, 2025, $47,710).

 

5

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

7.Property and Equipment

 

The continuity of the Company’s property and equipment is as follows:

 

   Equipment   Right of Use
Asset
   Prototype & Demo
Untis
   Construction in
Process
   Total 
Cost                    
At December 31, 2024  $248,254   $1,186,874   $774,566   $119,388   $2,329,082 
Additions   -    -    -    87,119    87,119 
Transfers   -    -    292,310    (206,507)   85,803 
Disposals   (8,453)   -    -    -    (8,453)
At December 31, 2025  $239,801   $1,186,874   $1,066,876   $-   $2,493,551 
Additions   -    -    90,000    -    90,000 
Transfers   -    -    -    -    - 
At September 30, 2026  $239,801   $1,186,874   $1,156,876   $-   $2,583,551 
                          
Accumulated Depreciation                         
At December 31, 2024  $189,564   $617,062   $762,519   $-   $1,569,145 
Depreciation for disposal   -    -    -    -    - 
Depreciation for the year   22,791    193,417    36,405    -    252,613 
At December 31, 2025  $212,355   $810,479   $798,924   $-   $1,821,758 
Depreciation for disposal   -    -    -    -    - 
Depreciation for the period   6,577    127,528    174,957    -    309,062 
At September 30, 2026  $218,932   $938,007   $973,881   $-   $2,130,820 
                          
Net Book Value                         
At December 31, 2025  $27,446   $376,395   $267,952   $-   $671,793 
At September 30, 2026  $20,869   $248,867   $182,995   $-   $452,731 

 

During the nine months ended September 30, 2026, equipment depreciation recorded to cost of revenue was $3,804 (December 31, 2025 - $126,568) to property and equipment related to Hexwave demo units.

 

During the nine months ended September 30, 2026, the Company reclassified finished goods inventory of $90,000 (December 31, 2025 - $85,803).

 

During the year ended December 31, 2025, the Company disposed of assets with a carrying value of $8,453 for $nil proceeds.

 

8.Intangible Assets

 

The continuity of the Company’s intangible assets is as follows:

 

   MIT licenses   Intellectual
property
   Total 
Balance, December 31, 2024  $373,009   $2,198,684   $2,571,693 
Amortization   (34,108)   (538,453)   (572,561)
Balance, December 31, 2025  $338,901   $1,660,231   $1,999,132 
Amortization   (25,581)   (403,871)   (429,452)
Balance, September 30, 2026  $313,320   $1,256,360   $1,569,680 

 

Intangible assets including MIT license and Battelle license, encompassing payments in connection to reimbursement of global patent filing costs and annual maintenance fees. Additionally, intellectual property was generated through the reverse take over (“RTO”) transaction closed during the year ended December 31, 2021, and became ready for use during the year ended December 31, 2022. The remaining useful life of the intangible assets are as follows: MIT license 9.25 years, Battelle license nil years, and intellectual property 2.25 years.

 

6

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

8.Intangible Assets (continued)

 

During the nine months ended September 30, 2026, $429,452 of amortization expense was allocated to HEXWAVE cost of revenues (September 30, 2025 - $381,711).

 

(a)MIT License Agreements

 

The Company, through its wholly owned subsidiary Liberty Defense Technologies Inc. (“LDT”), has entered into agreements with the Massachusetts Institute of Technology (“MIT”) and MIT’s Lincoln Laboratory (“MIT LL”), including an exclusive patent licence agreement between MIT and LDT dated September 10, 2018, as amended from time to time (the “Licence Agreement”), a technology transfer agreement between LDT and MIT LL, effective August 24, 2018 (the “Technology Transfer Agreement”), and a cooperative research and development agreement between LDT and MIT dated as of December 21, 2018 (“CRADA”), such agreements providing LDT with an exclusive licence for patents, design assets and MIT LL technical expertise related to active three-dimensional imaging technology that are the technology behind the HEXWAVE product.

 

The obligations under the Technology Transfer Agreement and the CRADA have now been completed. Liberty may consider extending the CRADA (and therefore changing its scope) if it determines that additional MIT LL technical expertise related to active three-dimensional imaging technology is required. Pursuant to the License Agreement, LDT has been granted the exclusive rights to MIT’s patent in “multistatic sparse array topology for FFT-based field imaging” (MIT Case No. l 8409L) (the “Patent”), which is being utilized in the development and application of the HEXWAVE product. The License Agreement is to be in effect until the expiration of the Patent, which is 10 years (December 2035). In granting LDT such patent rights, the Company shall pay MIT, in addition to patent filling costs, an annual fees as follows: 1) $20,000 for 2019 (paid); $50,000 for 2020 (paid); $60,000 for 2021 (paid); $100,000 for 2022 (paid); $nil for 2023, $40,000 for 2024 (paid),

 

$200,000 for 2025 (paid), and $350,000 for 2026 (payable) and thereafter; and 2) a royalty of 5.7% of all gross amount billed licensed products (HEXWAVE) of the Company.

 

During the nine months ended September 30,2026, the Company accrued royalty payments of $67,260 (December 31, 2025, $44,916).

 

(b)Battelle Memorial License Agreement

 

On March 22, 2021, the Company, through its wholly owned subsidiary DrawDown Detection, Inc. has entered into an agreement (“Battelle License Agreement”) with Battelle Memorial Institute (“Battelle”), which operates the Pacific Northwest National Laboratory (“PNNL”), to license the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe scanner technologies. The agreement, as amended from time to time, provides the Company with a three-year exclusive license for certain patents, which subsequently converted to a non-exclusive license for the remaining life of the patents. The agreement also provides the Company with a non-exclusive license for certain other patents for their remaining lives.

 

As consideration for the Battelle License Agreement, the Company paid $30,000 upon signing and $30,000 six months after.

 

Under the Battelle License Agreement, the Company shall pay a five percent royalty on gross sales less any returns, repayments, or rejections, that pertain to the production utilizing the license agreement (HD-AIT), and a twenty-five percent royalty on all sublicensing revenues if permitted under the contract guidelines.

 

During the nine months ended September 30, 2026, the Company accrued royalty payments of $nil (December 31, 2025, $nil).

 

The Company is required to pay a minimum royalty amount as follows, unless the agreement is terminated:

 

7

 

 

Liberty Defense Holdings, Ltd. 

Notes to the Condensed Interim Consolidated Financial Statements 

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts) 

For the three and nine months ended September 30, 2026, and 2025

 

8.Intangible Assets (continued)

 

(b)Battelle Memorial License Agreement (continued)

 

   Amounts 
Year 2021 (paid)  $50,000 
Year 2022 (paid)   50,000 
Year 2023 (paid)   100,000 
Year 2024 (paid)   200,000 
Year 2025 (paid)   200,000 
Year 2026 and each year thereafter (payable)   200,000 

 

The Company is obligated reimburse Battelle for ongoing patenting expenses, as well as past patenting expenses in the total amount of $50,000, from which $50,000 has been paid.

 

As at September 30, 2026, the Company has a balance payable of $150,000 (December 31, 2025, $200,000).

 

9.Loans Payable

 

(a)Related Party Loans

 

During the nine months ended September 30, 2026, the Company received working capital loans from related parties in the amount of $327,046. The Company did not receive working capital loans from related parties during the fiscal year ended December 31, 2025. These loans, unsecured and non-interest bearing, lack specified maturity dates. As of September 30, 2026, all loans were fully repaid.

 

   Amounts 
Balance, December 31, 2024  $74,658 
Repayments   (74,658)
Balance, December 31, 2025  $- 
Additions   327,046 
Repayments   (327,046)
Balance, September 30, 2026  $- 

 

(b)Short Term Loans

 

During the year ended December 31, 2024, the Company obtained a secured business loan of $420,000 from Blade Funding with a 32-week term. The loan carries an annual interest rate of 11.50%, requires weekly payments of $13,125. The loan matured on January 19, 2025. As at September 30, 2026, the balance outstanding was $nil (December 31, 2025 - $nil). During the year ended December 31, 2025, the Company fully repaid this loan.

 

   Amounts 
Balance, December 31, 2024  $26,250 
Repayments   (26,250)
Balance, December 31, 2025 and September 30, 2026  $- 

 

8

 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

10.Parabilis Term Loan

 

On August 22, 2024, the Company secured a $1,800,000 business term loan from PFF, LLC (“Parabilis”). The loan has a term of 104 weeks with an annual interest rate of 17.99% and is scheduled to mature on August 15, 2026. The agreement was amended on March 15, 2025, July 15, 2025, August 14, 2025, and September 1, 2025, with additional advancements totaling $650,000 and amending the payment schedule. Repayments of principal commenced in October 2025 with interest only payments through September 2025. The remaining contractual repayments approximate the carrying value of the term loan and are payable over eight months. See Note 10(a) regarding collateral.

 

   Amounts 
Balance, December 31, 2024  $1,921,687 
Additions   650,000 
Accrued interest and fees   384,047 
Repayments   (333,017)
Balance, December 31, 2025  $2,622,717 
Accrued interest and fees   143,404 
Repayments   (2,766,121)
Balance, September 30, 2026  $- 

 

11.Factoring and Credit Line Liabilities

 

(a)Parabilis Credit Line

 

On August 22, 2024, the Company entered into a secured revolving credit line agreement with Parabilis for up to $2,500,000. The borrowing base for the credit line is determined based on the following percentages: 90% of eligible billed receivables, 65% of eligible unbilled receivables, and 30% of eligible delivery orders. The aggregate of eligible billed and unbilled receivables, along with eligible delivery orders, establishes the Company’s borrowing capacity under the credit line.

 

When invoicing occurs, payments on the invoices are applied directly to the outstanding principal and interest on the credit line. The revolving credit facility had a maturity date of August 31, 2025, which was then amended on September 1, 2025, to mature on May 31, 2026, and will automatically renew for one-year periods unless the lender has notified the borrower at least 90 days in advance of the current maturity date will not renew. The facility carries an interest rate of 14.99% per annum. The Company shall pay a monthly commitment fee equal to 0.083% multiplied by the line of credit balance at the end of each month.

 

The Parabilis term loan and credit line are secured by all tangible and intangible personal property of the Company, wherever located, whether currently owned or acquired in the future. As of September 30, 2026, the balance has been paid in full.

 

   Amounts 
Balance, December 31, 2024  $983,671 
Additions   683,017 
Accrued interest and fee   169,279 
Repayments   (1,056,136)
Balance, December 31, 2025  $779,831 
Additions   2,754,192 
Accrued interest and fees   104,555 
Repayments   (3,638,578)
Balance, September 30, 2026  $- 

 

9 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

12.Leases

 

The Company’s lease liabilities as at September 30, 2026, and December 31, 2025, are as follows:

 

   Right of use
liability
 
Balance, December 31, 2024  $708,825 
Finance costs   44,882 
Lease cancelation   (18,514)
Lease payments   (198,958)
Balance, December 31, 2025  $536,235 
Finance costs   35,879 
Lease payments   (218,552)
Balance, September 30, 2026  $353,562 
Less current portion   245,389 
Non-current lease liability  $108,173 

 

During the year ended December 31, 2025, the Company was notified one of the leases being nulled due to the owners selling the building. The lease was canceled but the Company’s right to the building was retained until September 30, 2025.

 

Minimum lease payments are as follows:

 

   September 30,
2026
   December 31,
2025
 
Maturity analysis - contractual undiscounted cash flows          
One year or less  $245,387   $238,567 
Two to five years   133,579    358,949 
Six years and thereafter   -    - 
Total lease liabilities  $378,966   $597,516 
Lease liabilities included in the statement of financial position  $353,562   $536,235 
Current  $245,389   $235,834 
Non-current  $108,173   $300,401 

 

During the nine months ended September 30, 2026, the Company recorded a lease expense of $12,000 (December 31, 2025-$6,000) related to short-term leases not meeting the criteria for capitalization under IFRS 16.

 

13.Share Capital

 

(a) Common share transactions for the nine months ended September 30, 2026

 

i)On January 15, 2026, the Company closed the second and final tranche of the December 2025 non-brokered private placement for additional gross proceeds of $624,002 (CAD$867,506) through the issuance of 87,626 units at a price of CAD$9.90 per unit. Each unit comprised one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share at an exercise price of CAD$13.50 per share, exercisable from March 17, 2026, to January 15, 2028. The warrants were allocated a residual value of $56,452. In connection with the private placement, the Company issued an aggregate of 5,045 broker warrants to agents under terms and conditions substantially identical to those of the unit warrant. The broker warrants were allocated a fair value of $13,087 (CAD$18,194). Additionally, the Company paid commissions and legal expenses of $48,490 (CAD$67,413).

 

10 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

13.Share Capital (continued)

 

(a) Common share transactions for the nine months ended September 30, 2026 (continued)

 

ii)On April 21, 2026, the Company priced an initial public offering in the United States consisting of 3,673,638 common shares at a price of $4.50 per share for gross proceeds of $16,531,371 and, in lieu of common shares for certain investors, 770,807 pre-funded warrants at a purchase price of $4.4999 per pre-funded warrant for gross proceeds of $3,468,554. The common shares commenced trading on the Nasdaq Capital Market on April 22, 2026, under the symbol "DETX". The offering closed on April 23, 2026, resulting in aggregate gross proceeds of $19,999,925. The Company incurred commissions and legal expenses of $2,733,420 in connection with the offering, of which $2,259,367 was allocated to the common shares and $454,053 was allocated to the pre-funded warrants.

 

The pre-funded warrants were classified as equity instruments in accordance with IAS 32, Financial Instruments: Presentation, as they represent the right to acquire a fixed number of the Company's common shares for a fixed exercise price denominated in the Company's functional currency at the date of issuance. The gross proceeds received from the issuance of the pre-funded warrants were recorded within equity reserves and will be transferred to share capital upon exercise. As equity instruments, the pre-funded warrants are not subsequently remeasured.

 

iii)On July 24, 2026, the Company settled a total of $82,485 (CAD$117,000) of indebtedness with a certain creditor by issuing 23,306 shares valued at $82,485. No gain or loss was recognized on the settlement.

 

iv)On July 29, 2026, a total of 340,121 warrants expired with an exercise price of CAD$15.75. These broker warrants had a fair value of $45,209 and the reserve value was reclassified to share capital.

 

v)During the nine months ended September 30, 2026, a total of 736 common shares were issued pursuant to the RSUs with a fair value of $59,797.

 

(b) Common share transactions for the year ended December 31, 2025

 

i)On January 6, 2025, the Company received $2,071,851 (CAD$2,977,851) from the exercise of 120,317 share purchase warrants after electing, on December 31, 2024, to exercise its acceleration right for a total of 277,778 warrants granted on December 19, 2024, pursuant to a private placement. As a result, the remaining 157,461 unexercised warrants expired.

 

ii)On March 20, 2025, the Company closed a non-brokered private placement for gross proceeds of $3,479,351 (CAD$5,001,183). The Company issued 67,356 units (each a “Unit”) of the Company at a price of CAD$74.25 per Unit. Each Unit comprised of one common share and one-half common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the Company at a price of CAD$92.25 for a period of 24 months and is subject to an accelerated expiry at the Company’s election under certain conditions. The warrants were allocated a residual value of $263,584. In connection with the non-brokered private placement, the Company issued 4,715 finder warrants. Each finder’s warrant will be exercisable to purchase one common share for a period of 24 months at an exercise price of CAD$74.25. The broker warrants were allocated a fair value of $84,183 (CAD$121,004). Additionally, the Company paid commissions and legal expenses of $420,424 (CAD$600,650).

 

iii)On April 1, 2025, a total of 78 shares were issued pursuant to the exercise of 78 warrants, resulting in proceeds of $3,704 (CAD$5,285). Residual value in the amount of $nil was reversed.

 

iv)On April 13, 2025, a total of 478 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $5,498 and the reserve value was reclassified to share capital.

 

11 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

13.Share Capital (continued)

 

(b) Common share transactions for the year ended December 31, 2025 (continued)

 

v)On May 9, 2025, a total of 309 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $3,816 and the reverse value was reclassified to share capital.

 

vi)On June 6, 2025, a total of 206 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $1,892 and the reverse value was reclassified to share capital.

 

vii)On July 29, 2025, the Company closed a non-brokered private placement for gross proceeds of $3,199,767 (CAD$4,399,996). The Company issued 444,444 units (each a “Unit”) of the Company at a price of CAD$9.90 per Unit. Each Unit comprised of one common share and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the Company at a price of CAD$15.75 for a period of 12 months and is subject to an accelerated expiry at the Company’s election under certain conditions. The warrants were allocated a residual value of $nil. Additionally, the Company issued 16,000 broker warrants with a fair value of $38,472 (CAD$52,902). The Company paid commissions and legal expenses of $137,898 (CAD$189,781).

 

viii)On October 31, 2025, the Company received gross proceeds of $1,353,116 (CAD$1,895,093) from the exercise of 120,323 warrants.

 

ix)On December 31, 2025, the Company closed the first tranche of a non-brokered private placement for gross proceeds of $1,274,365 (CAD$1,747,172), through the issuance of 176,482 units at a price of CAD$9.90 per unit. Each unit comprised one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share at an exercise price of CAD$13.50 per share, exercisable from March 2, 2026, to December 31, 2027. The Company issued an aggregate of 7,915 broker warrants with a fair value of $20,866 (CAD$28,608). The warrants were allocated a residual value of $115,851 (CAD$158,833). The Company paid commissions and legal expenses of $57,331 (CAD$78,356).

 

x)During the year ended December 31, 2025, a total of 4,758 common shares were issued pursuant to the RSUs with a fair value of $383,471.

 

14.Equity Reserves

 

(a) Share-based compensation

 

The Company maintains an Omnibus Equity Incentive Plan (the “Incentive Plan”) which is comprised of stock options, restricted share units (“RSUs”), performance share units (“PSUs”), and deferred share units (“DSUs”). The maximum number of common shares reserved for issuance, in the aggregate, under the Incentive Plan is 10% of the aggregate number of common shares issued and outstanding to be granted to directors, officers, employees, and consultants under certain restrictions.

 

Unless the Board decides, or the grant agreement specifies otherwise, the stock options will vest in two years with quarterly intervals following the date of such grant. The Board shall fix the exercise price of any stock option when such stock option is granted, which shall not be less than the closing price of the common shares on the Exchange on the day prior to the date of grant (the “Market Value”). A stock option shall be exercisable during a period established by the Board, which shall commence on the date of the grant and shall terminate no later than ten (10) years after the date of grant of the award or such shorter period as the Board may determine.

 

With respect to RSUs, the specific provisions of the RSU plan, eligibility, vesting period, terms of the RSUs and the number of RSUs granted are to be determined by the Board of Directors at the time of the grant.

 

12 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

14.Equity Reserves (continued)

 

(a) Share-based compensation (continued)

 

With respect to PSUs, the specific provisions of the PSU plan, eligibility, vesting period, terms of the PSUs and the number of PSUs granted are to be determined by the Board of Directors at the time of the grant.

 

The continuity of the number of stock options issued and outstanding are as follows:

 

   Number of stock   Weighted average 
   options   exercise price 
Outstanding, December 31, 2024   71,717   CAD$ 58.05 
Cancelled   (15,329)    59.96 
Granted   54,444     13.69 
Outstanding, December 31, 2025   110,832   CAD$ 35.85 
Expired   (2,233)    231.16 
Outstanding, September 30, 2026   108,599   CAD$ 31.83 

 

As at September 30, 2026, the number of stock options outstanding and exercisable were:

 

   Outstanding   Exercisable 
Expiry date  Number of stock
options
   Exercise price   Remaining
contractual life
(years)
   Number of stock
options
 
1-Nov-26   944    CAD$ 207.00    0.09    944 
14-Jan-27   222    CAD$ 162.00    0.29    222 
15-Apr-27   1,111    CAD $ 26.55    0.54    1,111 
26-Apr-27   2,633    CAD$ 184.50    0.57    2,633 
2-Jul-27   5,556    CAD$ 10.80    0.75    5,556 
21-Nov-27   133    CAD$ 99.00    1.14    133 
26-Apr-28   111    CAD $ 81.00    1.57    111 
16-Oct-28   1,778    CAD $ 85.50    2.05    1,778 
30-Dec-29   51,667    CAD $ 38.25    3.25    46,181 
2-Apr-30   3,333    CAD $ 37.80    3.51    2,083 
30-Sep-30   41,111    CAD $ 12.15    4.00    41,111 
September 30, 2026   108,599              101,863 

 

During the nine months ended September 30, 2026, the Company recognized stock-based compensation related to stock options totaling $300,793 (September 30, 2025 – $1,032,541). Of this amount, $10,191 was recorded as stock-based compensation in the HEXWAVE cost of revenue (September  30, 2025 – $13,747), and $10,264 was recorded as stock-based compensation in cost of contract revenue (September 30, 2025 - $2,765).

 

The fair value of the stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:

 

   September 30,
2026
   December 31,
2025
 
Risk-free interest rate   Nil   2.52%
Expected dividend yield   Nil   Nil 
Stock price volatility   Nil   155.49%
Expected life (in years)   Nil   5 years 
Stock price   Nil   CAD$ 13.50 

 

13 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

14.Equity Reserves (continued)

 

(b) Restricted share units (“RSU”)

 

Restricted share units granted for the nine months ended September 30, 2026:

 

i)On September 24, 2026, the Company granted 23,888 RSUs to board members; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 24, 2031, and vests 100% on September 24, 2027.

 

ii)On September 24, 2026, the Company granted 255,000 RSUs to employees; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 24, 2031, and vests 100% on September 24, 2028.

 

iii)On September 30, 2026, the Company granted 40,000 RSUs to an employee; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 30, 2031, and vests 100% on September 30, 2027

 

The estimated fair value of the equity settled RSUs granted as of September 30, 2026, was $670,573 (December 31, 2025 – $60,998) and will be recognized as an expense over the vesting period of the RSUs. The fair value of the equity settled RSUs as at the grant date was determined with reference to the market value of the common shares of the Company at the grant date.

 

Restricted share units granted for the year ended December 31, 2025:

 

i)During the year ended December 31, 2025, a total of 4,758 common shares were issued pursuant to the exercise of RSUs.

 

ii)On August 7, 2025, the Company granted 1,111 RSUs to consultants; these RSUs shall be settled with common shares of the Company, have an exercise period that expires on January 1, 2029, and vest at 100% on January 1, 2026.

 

iii)On December 12, 2025, the Company granted 7,149 RSUs to a contractor; these RSUs shall be settled with common shares of the Company, have an exercise period that expires December 12, 2029, and vests 100% on December 12, 2026.

 

The following table summarizes the movements in outstanding RSUs:

  

   Number of
equity settled
RSUs
   Grant Price 
Outstanding, December 31, 2024   11,918   CAD$ 180.45 
Granted   8,260   10.91 
Exercised   (4,758)  115.88 
Outstanding December 31, 2025   15,420   CAD$ 55.51 
Exercised   (736)  113.13 
Cancelled   (1,672)  178.89 
Granted   318,888   2.97 
Outstanding, September 30, 2026   331,900   CAD$ 4.28 

 

14 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025

 

14.Equity Reserves (continued)

 

(b) Restricted share units (“RSU”) (continued)

 

   Outstanding   Exercisable 
Expiry date  Number of
restricted share
units
   Grant Price   Remaining
contractual life
(years)
   Number of
restricted share
units
 
26-Apr-27   444   CAD$ 198.00    0.57    444 
16-Oct-28   2,419   CAD$ 76.50    2.05    2,419 
1-Jan-29   1,111   CAD$ 12.15    2.26    1,111 
28-Feb-29   1,889   CAD$ 58.50    2.42    1,889 
12-Dec-29   7,149   CAD$ 10.58    3.20    - 
24-Sep-31   278,888   CAD$ 2.96    4.99    - 
30-Sep-31   40,000   CAD$ 3.00    5.00    - 
September 30, 2026   331,900             5,863 

 

A total of 5,863 RSU’s were vested as at September 30, 2026.

 

During the nine months ended September 30, 2026, the Company recognized stock-based compensation related to RSUs in the amount of $130,154 (September 30, 2025 – $25,017).

 

(c) Share purchase warrants

 

The continuity of the number of share purchase warrants outstanding is as follows:

 

   Warrants   Exercise 
   outstanding   Price 
Outstanding, December 31, 2024   446,109   CAD$54.90 
Issued   683,234    19.32 
Expired   (169,855)   32.79 
Exercised   (240,718)   20.27 
Outstanding December 31, 2025   718,770   CAD$36.45 
Issued   92,672    13.50 
Expired   (340,121)   15.75 
Outstanding September 30, 2026   471,321   CAD$47.76 

  

The fair value of the compensation warrants was estimated using the Black-Scholes option valuation model with the following weighted average assumptions:

 

   September 30,   December 31, 
   2026   2025 
Risk-free interest rate  2.90%  2.88%
Expected dividend yield  Nil   Nil 
Stock price volatility  93.11%  94.42%
Expected life (in years)  2 years   1.4 years 
Share price on grant date  CAD$ 9.00   CAD$ 41.04 
Fair value share purchase warrants  CAD$ 3.61   CAD$ 7.38 

 

15 

 

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

14.Equity Reserves (continued)

 

(c)Share purchase warrants (continued)

 

The outstanding number of share purchase warrants is as follows:

 

   Outstanding 
Expiry date  Number of warrants   Exercise price   Remaining
contractual life
(years)
 
05-Oct-26   39,617   CAD$135.00    0.01 
05-Oct-26   1,349   CAD$90.00    0.01 
18-Dec-26   45,162   CAD$24.75    0.22 
12-Jan-27   12,116   CAD$67.95    0.28 
05-Feb-27   2,222   CAD$90.00    0.35 
28-Feb-27   20,202   CAD$67.50    0.41 
27-Jun-27   423   CAD$90.00    0.74 
27-Jun-27   10,256   CAD$67.95    0.74 
20-Mar-27   33,678   CAD$92.25    0.47 
20-Mar-27   4,715   CAD$74.25    0.47 
27-Oct-27   3,215   CAD$123.75    1.07 
27-Oct-27   21,296   CAD$225.00    1.07 
31-Dec-27   176,482   CAD$13.50    1.25 
31-Dec-27   7,915   CAD$13.50    1.25 
15-Jan-28   87,627   CAD$13.50    1.29 
15-Jan-28   5,045   CAD$13.50    1.29 
September 30, 2026   471,321           

  

Effective April 23, 2026, certain outstanding CAD-denominated warrants were reclassified from equity to derivative financial liabilities following the Company's change in functional currency. Refer to Notes 3 and 15. The pre-funded warrants issued in connection with the Company's initial public offering are not included in the above reclassification, as they continue to qualify for equity classification under IAS 32.

 

(d)Pre-funded warrants

 

On April 23, 2026, in connection with the Company's U.S. initial public offering, the Company issued 770,807 pre-funded warrants at a purchase price of $4.4999 per warrant, for aggregate gross proceeds of $3,468,554. Each pre-funded warrant entitles the holder to acquire one common share of the Company at an exercise price of $0.0001 per share. The pre-funded warrants were immediately exercisable upon issuance and have no expiration date.

 

The pre-funded warrants were classified as equity instruments in accordance with IAS 32, Financial Instruments: Presentation, and the proceeds allocated to these instruments were recognized in equity reserves. The pre-funded warrants are not subsequently remeasured at fair value.

 

(e)Performance Shares

 

On March 17, 2021, Liberty deposited into escrow, and held in escrow, Operational Performance Shares (“OPS”) and Capital Market Performance Shares (“CMPS”) for certain directors, officers, and consultants of the Company upon the Company achieving certain performance milestones. Once these milestones were achieved the shares would be released. These performance shares included 4,444 of OPS and 19,496 of CMPS. In order to fair value these performance shares, management estimated the probability that the Company would issue the performance shares.

 

All CMPS have been issued in previous years upon the completion of all required milestones.

 

16

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

14.Equity Reserves (continued)

 

(e)Performance Shares (continued)

 

Operational Performance Shares

 

As at September 30, 2026, none of the 4,444 OPS have been released from escrow. The Company continues to assess the achievement of the applicable performance milestones. The estimated fair value of the OPS is CAD$800,000 which has an estimated vesting period of March 2027. During the nine months ended September 30, 2026, the Company recorded stock-based compensation in connection to OPS in the amounts of $63,880 (September 30, 2025 – $77,727). For the nine months ended September 30, 2026, and year ended December 31, 2025, none of the operational performance shares have been released from escrow.

 

15.Derivative Warrant Liability

 

Effective April 23, 2026, the Company changed its functional currency from the Canadian dollar ("CAD") to the U.S. dollar ("USD"). As a result, certain outstanding warrants with exercise prices denominated in CAD no longer satisfied the fixed-for-fixed criterion under IAS 32, Financial Instruments: Presentation, and were reclassified from equity to derivative financial liabilities.

 

Upon the change in functional currency, the derivative warrant liability was initially recognized at fair value. The historical carrying amount of the related warrant reserve was derecognized, and the difference between the historical carrying amount and the initial fair value of the derivative warrant liability was recognized in the condensed interim consolidated statement of loss and comprehensive loss.

 

Following initial recognition, the derivative warrant liability is measured at fair value at each reporting date, with changes in fair value recognized in profit or loss in accordance with IFRS 9, Financial Instruments.

 

   Amounts 
Balance, December 31, 2024 and 2025  $- 
Initial recognition on April 23, 2026   476,390 
Change in fair value   (451,372)
Balance, September 30, 2026  $25,018 

 

The fair value of the derivative warrant liability was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   September 30, 
   2026 
Risk-free interest rate   3.91%
Expected dividend yield   Nil 
Stock price volatility   78.28%
Expected life (in years)   0.71 years 
Share price at measurement date  $2.10 
Fair value share purchase warrants  $0.38 

 

The derivative warrant liability relates exclusively to legacy CAD-denominated unit warrants outstanding on April 23, 2026. Pre-funded warrants issued in connection with the Company's initial public offering and other equity-classified warrants are not included in the derivative warrant liability.

 

17

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

16.Loss Per Share

 

Basic loss per share is calculated by dividing the net loss attributable to common shareholders by the weighted-average number of common shares outstanding during the period. The weighted-average number of common shares includes on a weighted-average basis from April 23, 2026, the shares issuable upon exercise of the 770,807 pre-funded warrants issued by the Company on April 23, 2026, as these warrants are exercisable for nominal consideration with no substantive vesting conditions.

 

For the three and nine months ended September 30, 2026, and 2025, the Company incurred net losses. Accordingly, potentially dilutive securities, including stock options, conventional share purchase warrants, restricted share units and performance shares, have been excluded from diluted loss per share because their inclusion would be anti-dilutive. Consequently, basic and diluted loss per share are the same.

 

   Three months ended September 30,   Nine months Ended September 30, 
   2026   2025   2026   2025 
Loss attributable to common shareholders  $(2,970,187)  $(2,967,764)  $(7,898,603)  $(10,510,206)
Weighted average number of shares   6,446,907    1,459,462    4,606,982    1,234,756 
Basic and diluted loss per share  $(0.46)  $(2.03)  $(1.71)  $(8.51)

 

17.Deferred Revenue and Revenue

 

Revenue recognized during the nine months ended September 30, 2026, and 2025, relates primarily to the sale of HEXWAVE units and related products and services, as well as revenue form contracts with the Transportation Security Administration (“TSA”) as further described in Note 18.

 

Deferred revenue as of September 30, 2026, was as follows:

 

Deferred Revenue  Amounts 
Outstanding, December 31, 2024   180,000 
Additions   189,795 
Refunds   (180,000)
Recongnized revenue   (94,254)
Outstanding, December 31, 2025   95,541 
Additions   338,242 
Recongnized revenue   (108,038)
Outstanding, September 30, 2026   325,745 

 

   Three months ended September 30,   Nine months ended September 30, 
Revenue  2026   2025   2026   2025 
TSA Contract Award HD-AIT   -    -    -    457,905 
TSA OA Development   -    -    -    246,944 
HD-AIT Phase II A   -    150,000    -    150,000 
HD-AIT Phase II B   82,759    -    357,759    - 
HEXWAVE units   618,462    129,049    1,220,390    861,500 
HEXWAVE Software, Training & Warranty, Interest   19,496    -    104,190    47,907 
Total Revenue  $720,717   $279,049   $1,682,339   $1,764,256 

 

18

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

18.Contract Awards

 

During the nine months ended September 30, 2026, the Company recognized total contract revenue of $357,759, recorded in revenue (September 30, 2025 – $854,849). Future revenue related to these contracts will be recognized as performance obligations are satisfied. As of September 30, 2026, all contract revenue has been completed, and no additional revenue is expected currently.

 

TSA HD-AIT Phase II B

 

On September 29, 2025, the Company received a contract award for $357,759 from TSA for the HD-AIT Phase II B option. The contract award is a follow-on option to the current HD-AIT development program to execute phase II to drive to a final hardware design capable of supporting future compliance efforts. Invoices will be issued once the milestones are reached based on the agreed upon timeline. As at September 30, 2026, the Company received $275,000 and had a receivable of $82,759 (September 30, 2025 - $nil, and $nil respectively). The balance remaining on the contract as of September 30, 2026, was $nil (September 30, 2025 - $357,759).

 

TSA HD-AIT Phase II B  Amounts 
Year 2026     
Milestone 3 (Q1 2026)  $100,000 
Milestone 4 (Q1 2026)   175,000 
Milestone 5 (Q3 2026) (payable)   82,759 
Total Contract Value  $357,759 

 

As of September 30, 2026, the Company recorded contract costs of $nil representing costs incurred for contract milestones not yet achieved less related impairment charges (December 31, 2025 - $152,421).

 

19.Supplemental Disclosure with Respect to Cash Flows

 

During the nine months ended September 30, 2026, and 2025, the Company paid $nil in income taxes in both periods, and paid interest of $404,901 and $483,898, respectively.

 

19

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

19.Supplemental Disclosure with Respect to Cash Flows (continued)

 

   Nine months ended September 30, 
   2026   2025 
Changes in non-cash working capital          
Amounts receivable and prepaids  $(560,440)  $(525,024)
Inventory   (851,497)   (360,015)
Loss on debt settlement   29,995      
Contract cost   152,421    268,952 
Accounts payable and accrued liabilities   (2,414,036)   235,882 
Deferred revenue   230,204    (9,964)
           
Net changes in non-working capital  $(3,413,353)  $(390,169)
           
Supplemental cash flow information          
Fair value of compensation brokers warrants  $13,087   $129,091 
Reclassification restricted shares units exercised   59,797    374,067 
Residual value allocated to warrants   56,452    263,584 
Fair value of warrants allocated to share capital on expiry   45,209    - 
Share issuance of debt   82,485    - 
Stock based compensation recorded in cost of revenue   20,455    20,814 
Transfer from inventory to PP&E   90,000    85,803 
Deferred financing costs applied to equity   803,698    - 
Intangibles capitalized to inventory   -    47,710 

 

20.Related Party Transactions

 

Compensation of key management personnel:

 

Key management personnel include persons having the authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The key management personnel of the Company are the members of the Company’s executive management team and Board of Directors. Compensation provided to key management personnel is as follows:

 

   Three months ended September 30,   Nine months ended September 30, 
   2026   2025   2026   2025 
Salaries  $291,846   $385,401   $1,114,511   $1,061,266 
Stock-based compensation   101,683    166,095    271,540    693,419 
   $393,529   $551,496   $1,386,051   $1,754,685 

 

As of September 30, 2026, the Company had a balance payable of $357,146 to key management personnel (September 30, 2025, – $197,021). This payable balance includes accounts payable and accrued liabilities relating to compensation to directors, officers, or their related companies, included in compensation of key management personnel. These related party balances are unsecured, non-interest bearing and have no specific terms of settlement.

 

During the nine months ended September 30, 2026, the Company received working capital loans in the amount of $327,046 (September 30, 2025 - $nil) from members of key management personnel or their related parties and repaid $327,046 (September 30, 2025 - $74,658). As at September 30, 2026, the outstanding balance is $nil (Note 8(a)) (December 31, 2025 – $nil).

 

20

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

21.Financial Instruments

 

As at September 30, 2026, the Company’s financial instruments comprise cash, trades receivables, accounts payable and accrued liabilities, lease liabilities and derivative warrant liabilities. The fair values of the Company’s financial instruments other than the derivative warrant liability, approximate their carrying values due to their short-term maturity or applicable market interest rates. Derivative warrant liabilities are measured at fair value at each reporting date (Note 15).

 

Fair value of financial instruments:

 

Financial instruments recorded at fair value on the consolidated statements of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The three levels of the fair value hierarchy are:

 

· Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities.

· Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly

· Level 3 – Inputs that are not based on observable market data.

 

The Company’s activities expose it to financial risks of varying degrees of significance, which could affect its ability to achieve its strategic objectives for growth and shareholder returns. The principal financial risks to which the Company is exposed are credit risk, liquidity risk and currency risk. The Board of Directors has overall responsibility for the establishment and oversight of the Company’s risk management framework and reviews the Company’s policies on an ongoing basis.

 

(a)Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, including accounts receivable terms. The Company’s cash is held through large Canadian, international, and foreign national financial institutions. The Company’s receivables primarily consist of GST receivable due from the Canadian government and trade receivables that the Company continues to collect. These trade receivables are primarily with continuing customers and are not subject to significant credit risk. As at September 30, 2026, the Company’s trade receivables totalling $720,710 are from four customers (December 31, 2025 - $470,263). The Company’s maximum exposure to credit risk is limited to the carrying amount of cash and accounts receivables.

 

(b)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. To mitigate this risk, the Company has a planning and budgeting process in place to determine the funds required to support its ongoing operations and capital expenditures.

 

The Company seek to raise sufficient funds through equity offerings or debt financings to meet its operating requirements, after considering existing cash balances and potential proceeds from the exercise of share purchase warrants and stock options. The Company's ability to obtain additional financing is subject to uncertainty, as discussed in Note 1.

 

As at September 30, 2026, the Company had cash of $3,720,790 (December 31, 2025 – $319,294) to settle current liabilities of $2,986,985 (December 31, 2025 – $8,616,300).

 

During the nine months ended September 30, 2026, the Company repaid all amounts outstanding under its commercial agreement with Viken Detection Corporation. As a result, the outstanding balance due to Viken was reduced to $nil as at September 30, 2026. Subsequent to the repayment, Viken terminated its security interest by filing a UCC-3 Termination Statement on June 11, 2026.

 

21

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

21.Financial Instruments (continued)

 

As at September 30, 2026, the amount due to Viken was $nil (December 31, 2025 – $603,379). The Company also repaid the outstanding Parabilis term loan and credit line balances during the nine months ended September 30, 2026. As at September 30, 2026, the amount due to Parabilis was $nil (December 31, 2025 – $3,402,548). See Notes 10 and 11(a) for activity related to the Parabilis loans during the nine months ended September 30, 2026.

 

(c)Market risk

 

This risk refers to the potential fluctuations in the fair value or future cash flows of a financial instrument due to changes in market prices. The Company is exposed to the following significant market risks:

 

Interest rate risk

 

Interest rate risk arises from changes in market rates of interest that could adversely affect the Company. The Company currently has interest-bearing financial instruments in relation to loans and line of credit (Note 9 and 10). The Company’s exposure to interest rate risk is minimal as the interest rates are at a fixed percentage on the term loan and credit line liability.

 

Foreign currency risk

 

The Company is exposed to currency risk by having balances and transactions in currencies that are different from its functional currency. The Company operates in foreign jurisdictions, which uses the U.S. dollar. The Company does not use derivative instruments to reduce upward, and downward risk associated with foreign currency fluctuations. The Company’s exposure to foreign currency risk is minimal.

 

Price risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company's earnings due to movements in individual equity prices or general movements in the level of the stock market.

 

As at September 30, 2026, the Company's exposure to equity price risk includes its derivative warrant liability, which is measured at fair value at each reporting date. Changes in the Company's share price and other valuation assumptions may result in gains or losses recognized in profit or loss.

 

The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

22.Capital Risk Management

 

The Company manages common shares, stock options, performance share units, restricted share units, share purchase warrants, and prefunded warrants as capital. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the development of its products and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.

 

The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares, issue debt, acquire or dispose of assets, or adjust the amount of cash on hand.

 

In order to facilitate the management of its capital requirements, the Company prepares expenditure budgets that are updated as necessary depending on various factors, including successful capital deployment and general industry conditions.

 

22

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

22.Capital Risk Management (continued)

 

In order to maximize ongoing development efforts, the Company does not pay out dividends. The Company’s investment policy is to keep its cash treasury on deposit in an interest-bearing chartered bank account. Cash consists of cash held with banks.

 

The Company's ability to fund its ongoing operations and product development plans is dependent on obtaining additional financing, as discussed in Note 1. The Company is not subject to externally imposed capital requirements.

 

There has been no change to the Company’s approach to capital management during the nine months ended September 30, 2026.

 

23.Segmented Information

 

The Company operates through three distinct segments: Corporate, HEXWAVE and Contract. The operating segments of the Company are based on the reports reviewed by the chief operating decision maker (“CODM”) in making strategic resource allocation decisions. The Company considers its CODM to be its CEO, who evaluate the operations of each reportable segment.

 

The CODM reviews the net income (loss) of each of these segments in allocating resources and evaluating operating performance. The corporate reporting segment covers the Company’s non-allocated, general overhead expenses, such as legal, compliance, accounting, head-office staff, and other such items. This reporting segment is reviewed for cost control and budgetary considerations.

 

The following tables summarize the Company’s segments for the nine months ended September 30, 2026, and 2025:

 

       For the nine months ended September 30, 2026 
   Corporate   HEXWAVE   Contract   Total 
    $    $    $    $ 
Revenue   -    1,324,580    357,759    1,682,339 
Cost of revenue   -    2,401,872    851,124    3,252,996 
Expenses                    
Salaries and consulting   570,447    1,025,051    1,415,547    3,011,045 
General and administrative   654,419    864,049    1,193,211    2,711,679 
Product development & tech   -    156,786    216,515    373,301 
Stock-based compensation   494,826    (8,591)   (11,865)   474,370 
Depreciation   -    131,016    180,926    311,942 
Legal and professional fees   352,653    151,094    208,653    712,400 
Total expenses   2,072,345    2,319,405    3,202,987    7,594,737 
                     
Other   (62,109)   (27,804)   (38,396)   (128,309)
Initial recognition of warrant liability   (1,130,376)   -    -    (1,130,376)
Gain on fair value change in warrant liability   (451,372)   -    -    (451,372)
Loss on debt settlement   -    12,598    17,397    29,995 
Interest expense   1,094    169,599    234,208    404,901 
Foreign exchange (gain) loss   8,370    -    -    8,370 
                     
Net loss for the period   (437,952)   (3,551,090)   (3,909,561)   (7,898,603)

 

23

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

23. Segmented Information (continued)

 

       For the nine months ended September 30, 2025 
   Corporate   HEXWAVE   Contract   Total 
    $    $    $    $ 
Revenue   -    909,407    854,849    1,764,256 
Cost of revenue   -    2,112,884    1,493,636    3,606,520 
Expenses                    
Salaries and consulting   700,908    894,238    1,234,899    2,830,045 
General and administrative   2,143,288    356,858    492,803    2,992,949 
Product development & tech   -    110,777    152,977    263,754 
Stock-based compensation   1,135,286    (8,742)   (12,073)   1,114,471 
Depreciation   -    79,720    110,089    189,809 
Legal and professional fees   334,091    182,694    252,291    769,076 
Total expenses   4,313,573    1,615,545    2,230,986    8,160,104 
                     
Other   23,940    -    -    23,940 
Interest expense   -    203,237    280,661    483,898 
                     
Net loss for the period   (4,337,513)   (3,022,259)   (3,150,434)   (10,510,206)

 

Geographic Breakdown

 

As at September 30, 2026, and 2025, all non-current assets are in the United States.

 

All revenue from contract segment was earned from one customer in the United States (September 30, 2025 – one customer in the United States).

 

For the nine months ended September 30, 2026, and 2025, revenues from the HEXWAVE segment attributable to the Company’s country of domicile, Canada, were $nil and $nil. Revenues attributable to customers in the United States totaled approximately $1,363,263 (September 30, 2025 - $909,407). The determination of revenues by geographic area is based on the location of the customer.

 

For the nine months ended September 30, 2026, the Company reported HEXWAVE revenues from three individual customers, each representing more than 10% of the Company's total consolidated revenues, of $315,000, $330,000 and $180,000, respectively (September 30, 2025 – $390,000 and $185,000 from two individual customers, respectively).

 

24

 

 

Liberty Defense Holdings, Ltd.

Notes to the Condensed Interim Consolidated Financial Statements

(Unaudited - Expressed in U.S. dollars, unless otherwise stated and per share amounts)

For the three and nine months ended September 30, 2026, and 2025 

 

24.Share Consolidation

 

On March 3, 2026, the Company’s Board of Directors approved a one-for-forty-five share consolidation of its common shares. The share consolidation became effective as of March 13, 2026. In accordance with TSX Venture Exchange requirements, the consolidation was approved by shareholders of the Company at a special meeting held on February 6, 2026.

 

Upon the effectiveness of the share consolidation, (i) every forty-five outstanding common shares were consolidated into one common share and (ii) the number of common shares issuable upon exercise of each outstanding option and warrant was proportionately decreased, and the exercise price of each outstanding option and warrant was proportionately increased.

 

No fractional shares were issued as a result of the share consolidation. The Company is authorized to issue an unlimited number of common shares without par value, which was not affected by the share consolidation.

 

Accordingly, all share and per share amounts for all periods presented in these financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the share consolidation as if it had occurred at the beginning of the earliest period presented.

 

25.Subsequent Events

 

Subsequent to September 30, 2026, the Company recorded:

 

·On October 5, 2026, a total of 40,966 share purchase warrants expired without being exercised.

 

·On October 29, 2026, a total of 1,374 RSUs were exercised.

 

·On October 31, 2026, a total of 4,444 performance share units were canceled.

 

·On November 1, 2026, a total of 944 stock options expired without being exercised.

 

·Subsequent to September 30, 2026, a total of 8,056 stock options were forfeited.

 

·Subsequent to September 30, 2026, a total of 5,000 RSUs were forfeited.

 

25

 

 

Exhibit 99.2

 

 

 

INNOVATIVE & REVOLUTIONARY Threat DETECTION

 

MANAGEMENT’S DISCUSSION AND ANALYSIS

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

(Expressed in U.S. dollars, unless otherwise stated and per share amounts)

 

Dated: November 13, 2026

 

Liberty Defense Holdings Ltd. (the “Company” or “Liberty”) has prepared this Management’s Discussion and Analysis (“MD&A”) as of November 13, 2026, and it should be read in conjunction with the Company’s unaudited condensed consolidated interim financial statements and related notes for the three and nine months ended September 30, 2026. Unless otherwise stated, all financial information has been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (“IASB”). All dollar amounts are expressed in U.S. dollars unless otherwise indicated. References to “$” are to U.S. dollars and references to “CAD$” are to Canadian dollars.

 

This MD&A contains forward-looking statements and forward-looking information (collectively, “forward-looking information”) based on management’s current expectations, estimates, assumptions and judgments regarding future events. Forward-looking information is often, but not always, identified by words such as “anticipate”, “believe”, “expect”, “intend”, “plan”, “may”, “will”, “should”, “estimate”, “predict”, “potential”, “continue”, and similar expressions, or statements that certain events or conditions “may”, “would”, “could” or “will” occur. Forward-looking information involves known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking information.

 

This MD&A includes forward-looking information regarding, among other things, the Company’s anticipated commercialization activities, future sales opportunities, operating activities, expenses, research and development initiatives, business strategy and growth opportunities. Such information is based on management’s current expectations, assumptions and estimates and is subject to significant business, economic, operational and competitive risks and uncertainties, many of which are beyond the Company’s control. Readers are cautioned not to place undue reliance on forward-looking information, as actual results may differ materially from those expressed or implied. Forward-looking information is provided solely for the purpose of assisting readers in understanding management’s current expectations regarding the Company’s future business activities and may not be appropriate for other purposes. The Company undertakes no obligation to update or revise any forward-looking information contained in this MD&A, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

 

Additional information relating to the Company is available on the Company's website at www.libertydefense.com and under the Company's profile on SEDAR+ at www.sedarplus.ca.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 1

 

 

Table of Contents Page
   
1 Overview 2
2 Results of Operations and selected annual information 8
3 Summary of Quarterly Results 11
4 Liquidity and Capital Resources 13
5 Commitments 22
6 Revenue 22
7 Contract Awards 23
8 Off-balance Sheet Arrangements 24
9 Transaction Between Related Parties 24
10 Subsequent Events 24
11 Financial Instruments 25
12 Other Requirements 26
13 Disclosure Controls and Procedures and Internal Controls over Financial Reporting 28

 

1.Overview

 

(a) Description of Business

 

Liberty Defense Holdings, Ltd. (“Liberty” or the “Company”) is a publicly traded company listed on NASDAQ (NASDAQ: DETX), the TSX Venture Exchange: (TSXV: SCAN), the Frankfurt Stock Exchange (Frankfurt: L2D), and the OTCQB (OTCQB: LDDFF). The Company was incorporated under the Business Corporations Act of Ontario on June 8, 2012. On July 27, 2020, Liberty continued its jurisdiction of incorporation from Ontario to British Columbia and is now governed by the Business Corporations Act of British Columbia.

 

The Company’s registered and records office is located at 1055 West Georgia Street, Suite 1500, Royal Centre, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada. Its head office is located at 187 Ballardvale Street, Suite 110, Wilmington, Massachusetts, 01887, USA.

 

The Company is engaged in the development and commercialization of advanced security detection technologies. Liberty’s flagship product, HEXWAVE™, utilizes millimeter wave technology and advanced 3D imaging to detect concealed threats. In addition to HEXWAVE™, the Company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning.

 

(b) Board Changes

 

a.Effective October 12, 2026, Jason Burinescu stepped down as Executive Chairman, and John Percival was appointed Executive Chairman.

 

b.Effective October 13, 2026, William Frain resigned as a member of the Board of Directors but continued to serve as Chief Executive Officer until October 31, 2026. Keith Teichmann was appointed Interim Chief Executive Officer effective November 1, 2026.

 

c.Effective October 16, 2026, Steve Karoly joined the Board of Directors.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 2

 

 

(c) License Agreements

 

Licence agreements values and descriptions:

 

   MIT licenses   Intellectual
property
   Total 
Balance, December 31, 2024  $373,009   $2,198,684   $2,571,693 
Amortization   (34,108)   (538,453)   (572,561)
Balance, December 31, 2025  $338,901   $1,660,231   $1,999,132 
Amortization   (25,581)   (403,871)   (429,452)
Balance, September 30, 2026  $313,320   $1,256,360   $1,569,680 

 

i)HEXWAVE™ Technology (intellectual property)

 

a.Active real-time 3D imaging technology licensed from MIT LL

 

Active video rate imaging technology was developed by the Massachusetts Institute of Technology Lincoln Labs (“MIT LL”) and the technology has been in development since 2014. In October 2017, a concept demonstrator (pre-prototype) of the core technology was successfully tested under environmental conditions by MIT LL.

 

MIT LL undertook 4 years of research and development, including building a working prototype and testing the technology in both lab and real electromagnetic environments. LDT worked with MIT LL to transfer the active imaging technology starting in Q4 2018. In September 2019, Liberty and MIT LL were recognized by the FLC (Federal Laboratory Consortium) for the 2019 Excellence in Technology Transfer Northeast Region.

 

With the exclusive global license agreement (the “License Agreement”) for the use of the active imaging technology, the Company has continued to develop HEXWAVE™ using the technology and concepts demonstrated by MIT LL. MIT LL, through the Technology Transfer Agreement (“TTA”) has transferred the intellectual property and understanding to Liberty’s Center of Excellence (“COE”) in order for the technology to be further refined and developed. As part of the commercialization and go to market strategy, the Company had identified certain required changes and entered into a Cooperative Research and Development Agreement (CRADA) with MIT LL to leverage off their existing experience and accelerate the development of certain aspects of HEXWAVE™. In addition to active imaging technology, the Company is also developing Automatic Threat Detection technology with the help of rich 3-dimension data and deep learning algorithms.

 

HEXWAVE™ Overview:

 

 

Since acquiring the License Agreement from MIT LL, Liberty has significantly advanced HEXWAVE™ which includes the active imaging technology, automated threat detection (“ATD”) and smart IoT technologies. This culminated in the demonstration of the four principal subsystems in September 2019. This step represented a significant de-risking of the product development phase.

 

b.Artificial intelligence and Deep Learning – Automatic Threat Recognition (“ATR”)

 

Automatic Threat Recognition utilizing deep learning algorithms was developed by Liberty to recognize person-borne concealed metal and non-metal threats. The 3-D data and images produced by the HEXWAVE™ are used to train and enhance the artificial intelligence engine using deep-learning algorithms.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 3

 

 

At a frame capture rate of 20 images per second, the algorithms can exploit the changes in person’s positioning from frame-to-frame, thus maximizing the total coverage area and threat detection performance.

 

ATR improves detection accuracy, reduces resources required for screening, and allows the security personnel to take necessary action instantly. As additional field data and images are collected by the system over time, our goal will be to continuously improve HEXWAVE™ and its threat detection performance by receiving real time updates to its algorithms as new and emerging threats are identified.

 

Global License Agreement – September 2018

 

The License Agreement for the use of the technology behind HEXWAVE™ with MIT is to be in effect until December 2035. Under the License Agreement, several milestones are required to be met to keep it in good standing. MIT continues to work closely with Liberty on developing this technology and amended the timeline to develop a beta prototype from on or before December 31, 2019, to removing the deadline entirely and replacing it with an in-plant inspection by MIT at regular intervals with at least six months between each such inspection. The amendment also included additional details in relation to changes on required commercial sales dates, required total net sales by year, and payment dates on its license agreement. Refer to SEDAR+ (www.sedarplus.ca) for further details on the MIT amendment.

 

HEXWAVE™ Key Discriminators

 

Central to positioning HEXWAVE™ is building on its key discriminators. These are enabled by the system architecture that aligns to key market needs. These include:

 

  · Detects metal & non-metal threat objects
  · Operates in both indoor and outdoor locations including both overt and covert applications
  · Protects privacy (no personal data is collected or analyzed)
  · ATD in real-time using rich 3D data and deep learning algorithms
  · Smart functionality provides connectivity to existing security systems (VMS, door locks, networks)
  · Routine software & artificial intelligence updates
  · Operationally agile (mobile and deployable across detection space)
  · High throughput (over 700 screens per hour) with precise secondary screening

 

About the Explosives and Weapon Detection Market

 

The aggregate markets associated with the explosives and weapon detection market are expected to total over $11 billion by 2025. The verticals most relevant to the growing Urban Security Market (“USM”) are public venues, secured perimeters & buildings, land transportation, government, and others (schools, hotels, casinos, places of worship, malls, workplace & community screening).

 

The complexity of the urban security threat environment has dramatically changed over the last decade, requiring a more proactive approach to preventing violent attacks against communities. Since the 9/11 events, the air transportation community has effectively deployed a combination of detection technologies that are being consistently upgraded in an attempt to “stay ahead” of evolving threats. The array of detection tools has largely been protecting access to aircraft systems as gated or “point” solutions. The public is forced to tolerate the delays associated with such inspections due to the extreme risks that explosives or weapons can have on an aircraft and its passengers.

 

In contrast, urban communities are largely unprotected against random acts of violence or use systems that significantly impede the flow of customers into and within business facilities. While the occasional violent act was more often considered an anomaly, the frequency and magnitude of violent attacks is forcing both businesses and governments to rethink how to move to more proactive measures. Since 2015, there have been over 300 mass shootings per year in the United States (“US”) at a pace of nearly one per day. There is a market-driven need for security detection that can be broadly deployed across nearly all public and private facilities. The base requirements are that they be both highly accurate and nonintrusive to our daily lives.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 4

 

 

Current Alternatives

 

The current alternatives in the United States market are typically restricted to:

 

·principally focusing on metal threats, therefore non-metal threats can potentially go undetected

·airport solutions which are not able to be used across other verticals and do not have the requisite throughput

·limited outdoor application and therefore hinder the capability of providing a layered defense for proactive threat detection

·requiring large, dedicated areas or space versus integration into existing infrastructure

·limited capability for integration into existing security systems command & control

 

About Liberty’s Management Team

 

Central to Liberty’s team is the technical and management expertise of its leadership. Keith Teichmann was appointed Interim Chief Executive Officer effective November 1, 2026, succeeding William Frain.

 

The Company's Chief Technology Officer, Jeffrey Gordon, previously worked at General Electric Global Research, developing roadmaps for imaging and sensor technologies. He has over 35 years of experience leading the development of innovative sensing products for military, medical, industrial, and commercial markets, including body scanners deployed at airport checkpoints throughout the United States and European Union.

 

Liberty’s Advisors

 

Liberty has assembled a group of Advisors that can provide unprecedented market access to several of our identified market verticals including the National Football League, law enforcement, federal and state government facilities, and former airport executives. A key aspect to Liberty’s success will be gaining access and developing the market for HEXWAVE™.

 

ii)MIT License Agreement Description and Commitments

 

The Company, through its wholly owned subsidiary Liberty Defense Technologies Inc. (“LDT”), has entered into agreements with the Massachusetts Institute of Technology (“MIT”) and MIT’s Lincoln Laboratory (“MIT LL”), including an exclusive patent licence agreement between MIT and LDT dated September 10, 2018, as amended from time to time (the “Licence Agreement”), a technology transfer agreement between LDT and MIT LL, effective August 24, 2018 (the “Technology Transfer Agreement”), and a cooperative research and development agreement between LDT and MIT dated as of December 21, 2018 (“CRADA”), such agreements providing LDT with an exclusive licence for patents, design assets and MIT LL technical expertise related to active three-dimensional imaging technology that are the technology behind the HEXWAVE™ product.

 

The obligations under the Technology Transfer Agreement and the CRADA have now been completed. Liberty may consider extending the CRADA (and therefore changing its scope) if it determines that additional MIT LL technical expertise related to active three-dimensional imaging technology is required. Pursuant to the License Agreement, LDT has been granted the exclusive rights to MIT’s patent in “multistatic sparse array topology for FFT-based field imaging” (MIT Case No. l 8409L) (the “Patent”), which is being utilized in the development and application of the HEXWAVE™ product. The License Agreement is to be in effect until the expiration of the Patent, which is about 10 years (December 2035). In granting LDT such patent rights, the Company is required to pay MIT, in addition to patent filling costs, annual fees as follows: $20,000 for 2019 (paid); $50,000 for 2020 (paid); $60,000 for 2021 (paid); $100,000 for 2022 (paid); $nil for 2023, $40,000 for 2024 (paid), $200,000 for 2025 (paid), and $350,000 for 2026 (payable) and thereafter. In addition, the Company is required to pay a royalty of 5.7% of all gross amount billed for licensed HEXWAVE™ products.

 

During the nine months ended September 30, 2026, the Company accrued $67,260 in royalty expenses under the MIT License Agreement (December 31, 2025, $44,916). The Company remains subject to the applicable annual licence fees and royalty obligations under the agreement.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 5

 

 

iii)Battelle Memorial Institute License Agreement Description and Commitments

 

On March 22, 2021, the Company, through its wholly owned subsidiary DrawDown Detection, Inc. has entered into an agreement (“Battelle License Agreement”) with Battelle Memorial Institute (“Battelle”), which operates the Pacific Northwest National Laboratory (“PNNL”), to license the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe scanner technologies. The agreement, as amended from time to time, provides the Company with a three-year exclusive license for certain patents, which subsequently converted to a non-exclusive license for the remaining life of the patents. The agreement also provides the Company with a non-exclusive license for certain other patents for their remaining lives.

 

As consideration for the Battelle License Agreement, the Company paid $30,000 upon signing and $30,000 six months after.

 

Under the Battelle License Agreement, the Company shall pay a five percent royalty on gross sales less any returns, repayments, or rejections, that pertain to the production utilizing the license agreement (HD-AIT), and a twenty-five percent royalty on all sublicensing revenues if permitted under the contract guidelines.

 

During the nine months ended September 30, 2026, the Company accrued royalty payments of $150,000 (December 31, 2025, $nil).

 

The Company is required to pay a minimum royalty amount as follows, unless the agreement is terminated:

 

   Amounts 
Year 2021 (paid)  $50,000 
Year 2022 (paid)   50,000 
Year 2023 (paid)   100,000 
Year 2024 (paid)   200,000 
Year 2025 (paid)   200,000 
Year 2026 and each year thereafter (payable)   200,000 

 

The Company is obligated to reimburse Battelle for ongoing patent-related expenses and previously incurred patent-related expenses totaling $50,000, all of which has been paid.

 

As at September 30, 2026, the Company has a balance payable of $150,000 (December 31, 2025, $200,000).

 

(d)HD-AIT Upgrade Kit

 

The HD-AIT Upgrade Kit is being developed pursuant to contracts awarded by the U.S. Transportation Screening Administration (“TSA”) to create a solution to aging high-definition advanced imaging technology (“HD-AIT”) systems currently in use in airports throughout North America and also can be implemented to upgrade HD-AIT systems around the globe. The Company believes that the potential modernization of body scanners installed at U.S. airports represents a market opportunity for its HD-AIT Upgrade Kit technology. The timing and extent of future deployments will depend on TSA requirements, procurement decisions and available funding.

 

(e)Recent Developments

 

From inception, Liberty set itself an aggressive product development timeline by pursuing a concurrent engineering and development approach and prior to its financial constraints had managed to deliver upon this timeline.

 

In addition to advancing HEXWAVE™ and the market for it, Liberty achieved several significant corporate milestones which include:

 

·Liberty Announces Closing of Final Tranche of LIFE Private Placement Raising a Total of $2.6 Million (January 2026)

·Liberty Defense Announces Confidential Submission of Draft Registration Statement for Proposed U.S. Initial Public Offering (January 2026)

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 6

 

 

·Liberty Defense Secures New Major U.S. Airport Contract, Fueling Momentum in Aviation Security (February 2026)

·Liberty Defense Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering (February 2026)

·Liberty Defense Secures Contract with Acclaimed Infectious Disease Laboratory for HEXWAVE Walkthrough Screening System (February 2026)

·Liberty Defense Announces Pricing of its U.S. Initial Public Offering (April 2026)

·Liberty Defense Appoints Seasoned Capital Markets Executive Will Hamilton to its Board of Directors (April 2026)

·Liberty Defense Deploys HEXWAVE at LaGuardia Terminal B, Expanding Footprint in High-Traffic U.S. Airports and announces Shares of Debt Settlement (May 2026)

·Liberty Defense Expands Aviation Footprint with New HEXWAVE Award at Major International Airport (June 2026)

·Liberty Announces Closing of Shares for Debt (July 2026)

·Liberty Announces Leadership Change (August 2026)

·Liberty Defense Previews the HEXWAVE I-Configuration at GSX 2026 for Entrances That Cannot Give Up a Lane (September 2026)

·Liberty Defense Enters Commercial Loss Prevention Market with Multi-Site HEXWAVE Agreement (September 2026)

·Liberty Defense Expands U.S. Distribution Footprint with New Agreement with VMI Security for HEXWAVE (September 2026)

·Liberty Defense and Wadsworth Solutions Announce Sale of HEXWAVE™ Systems to Cleveland Hopkins International Airport (October 2026)

·Liberty Defense Adds HEXWAVE Customers in Courts and Corrections Following Entry into Commercial Loss Prevention (October 2026)

·Liberty Defense Announces New Chairman to its Board of Directors (October 2026)

·Liberty Defense Announces New Board Member (October 2026)

 

(f) Outlook and Going Concern

 

Expenditures on research activities undertaken with the prospect of gaining new scientific or technological knowledge and understanding are recognized in the statement of loss as expenses when incurred.

 

Expenditures on development activities, where research results are used in planning or designing new or substantially improved products and processes, are recognized as intangible assets when the recognition criteria under IAS 38 are satisfied. Development expenditures that do not meet these criteria are recognized in the statement of loss as expenses when incurred.

 

The Company incurred in a total loss during the nine months ended September 30, 2026, of $7,898,603 and had cash outflows from operating activities of $11,227,106. Given the current stage of operations, the Company’s ability to continue as a going concern is contingent on its ability to obtain additional financing. While the Company has been successful in arranging financing in the past, there can be no assurance that it will be able to do so in the future.

 

During the nine months ended September 30, 2026, the Company completed financing transactions, including private placements and a public offering, for aggregate gross proceeds of approximately $20.6 million. Notwithstanding these financings, the Company continues to incur operating losses and negative operating cash flows and will require additional financing to support its ongoing operations and working capital requirements.

 

The application of the going concern concept is dependent upon the Company’s ability to generate future profitable operations and receive continued financial support from its creditors and shareholders. These condensed interim consolidated financial statements do not give effect to any adjustments that might be required should the Company be unable to continue as a going concern. Such adjustments could be material.

 

If the Company cannot generate sufficient future cash flows or obtain additional financing, this may delay the production timeline and shipments of backlogged orders, in addition to delaying necessary product cost reductions and improvements due to insufficient funds to hire personnel, manufacture products, and execute necessary product updates and revisions. Continued equity and/or debt financing is critical to support production and commercialization activities and the Company's efforts to achieve profitability.

 

Management plans to continue to pursue equity and/or debt financing to support operations. No definitive financing arrangements have been secured as of the date of this MD&A, and there can be no assurance that these financing efforts will be successful. Failure to maintain the support of creditors and obtain additional external financing may cause the Company to curtail operations and impair its ability to continue as a going concern. The outcome of these matters cannot be predicted at this time.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 7

 

 

These events and conditions indicate that a material uncertainty exists that might cast significant doubt upon the Company’s ability to continue as a going concern.

 

2.Results of Operations

 

Certain comparatives in prior periods may have been revised to conform to the current presentation.

 

During the three and nine months ended September 30, 2026, the Company reported net loss of $2,970,187 and $7,898,603 respectively (three and nine months ended September 30, 2025 – $2,967,764 and $10,397,546), and basic and diluted loss per share of $0.46 and $1.71, respectively (three and nine months ended September 30, 2025 – $2.03 and $8.51). Despite the accumulated losses, the Company's management continues to focus on scaling up production and commercialization of its primary technology, HEXWAVE™, and advancing the research and development of other technologies.

 

The net loss for the three and nine months ended September 30, 2026, and 2025 is comprised of the following items:

 

       Three months ended September 30,   Nine months ended September 30, 
   Note   2026   2025   2026   2025 
               $   $ 
Revenue  17 & 18                     
HEXWAVE revenue       637,958    129,049    1,324,580    909,407 
Contract revenue       82,759    150,000    357,759    854,849 
Total Revenue       720,717    279,049    1,682,339    1,764,256 
                         
Cost of revenue                        
HEXWAVE cost of revenue       821,248    838,101    2,401,872    2,112,884 
Contract cost of revenue       324,522    394,939    851,124    1,493,636 
Total cost of revenue       1,145,770    1,233,040    3,252,996    3,606,520 
Gross loss       (425,053)   (953,991)   (1,570,657)   (1,842,264)
                         
Engineering and Research and Development Expenses:                        
Product development & technology Costs       178,029    79,417    373,301    263,754 
Salaries and consulting fees  20    550,420    522,163    1,516,035    1,542,588 
Stock-based compensation  14 & 20    -    134    -    15,240 
Depreciation  7    110,779    57,300    311,942    189,809 
Office, rent & administration, travel, and miscellaneous       327,056    9,766    657,920    47,275 
                         
General & Administration Expenses                        
Salaries and consulting fees  20    817,165    273,845    1,495,010    1,287,457 
Legal and professional fees       131,571    80,693    712,400    769,076 
Stock-based compensation  14 & 20    131,332    122,412    474,370    1,099,231 
General, administrative and corporate expenses       438,518    719,821    2,053,759    2,945,674 
        2,684,870    1,865,551    7,594,737    8,160,104 
                         
 Operating Loss      $(3,109,923)  $(2,819,542)   (9,165,394)   (10,002,368)
                         
Other (income) expense:                        
Other income, net       (10,152)   (3,341)   (128,309)   (4,671)
Gain on initial recognition of warrant liability  15    199,505    -    (1,130,876)   - 
Gain on fair value change in warrant liability  15    (371,924)   -    (451,372)   - 
Loss on debt settlement       -    -    29,995    - 
Interest expense  9 & 10    33,649    142,966    404,901    483,898 
Foreign exchange (gain) loss       9,186    8,597    8,870    28,611 
        (139,736)   148,222    (1,266,791)   507,838 
                         
Net loss for the period      $(2,970,187)  $(2,967,764)   (7,898,603)   (10,510,206)

 

i)Revenue

 

Three months ended September 30, 2026 vs 2025

 

HEXWAVE™ revenue for the three months ended September 30, 2026, was $637,958, compared to $129,049 for the corresponding period in 2025. The increase was primarily attributable increased HEXWAVE™ units, as well as revenue recognized from software and maintenance services during the current period.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 8

 

 

Contract revenue for the three months ended September 30, 2026, was $82,759, compared to $150,000 for the corresponding period in 2025. The decrease was primarily attributable to the completion of contract programming activities.

 

Nine months ended September 30, 2026 vs 2025

 

HEXWAVE™ revenue for the nine months ended September 30, 2026, was $1,324,580, compared to $909,407 for the corresponding period in 2025, representing an increase of $415,173, or 46%. The increase was primarily attributable to higher HEXWAVE™ units delivered during the current period.

 

The Company expects revenue activity to continue to increase during the remaining of 2026 as production capacity and inventory availability improve following the completion of the financing transactions in April 2026. These initiatives are expected to support increased customer shipments and deployments.

 

During the nine months ended September 30, 2026, Contract revenue was $357,759 compared to $854,849 during the nine months ended September 30, 2025, representing a decrease of $497,090, or 58.1%. The decrease was primarily attributable to contract programming work performed during the prior period, resulting in lower contract programming revenue recognized during the current period.

 

During the nine months ended September 30, 2026, the Company delivered thirteen HEXWAV™ units at an average selling price of approximately $90,769 per unit, compared to twelve units delivered during the corresponding period in 2025 at an average selling price of approximately $75,784 per unit. The higher volume of deliveries was primarily attributable to higher sales for the current period vs. prior year, as well as management's continued focus on manufacturing optimization and operational efficiency initiatives.

 

During the nine months ended September 30, 2026, HEXWAVE™ revenue of $1,324,580 was accompanied by cost of revenue of $2,401,872, resulting in a gross loss of $1,077,292. For the three months ended September 30, 2026, HEXWAVE™ generated a gross loss of $183,290. The Company continues to evaluate opportunities to improve manufacturing efficiencies and reduce production costs as commercial deployments increase.

 

Contract revenue relates primarily to development programs that were completed during the nine months ended September 30, 2026. As of September 30, 2026, the Company had satisfied the remaining performance obligations under its existing TSA development contract, and no additional revenue is currently expected from this program. However, additional contract revenue may be generated from future customer contracts and development opportunities.

 

ii)Cost of revenues

 

Three months ended September 30, 2026 vs 2025

 

Cost of revenue for the three months ended September 30, 2026, was $1,145,770, compared to $1,233,040 for the corresponding period in 2025, representing a decrease of $87,270, or 7.1%. The decrease was primarily attributable to slightly lower HEXWAVE™ cost of revenue as additional inventory was recognized in cost of revenue during the prior period. This decrease was also attributable to lower contract cost of revenue, reflecting the completion of the Company's development program and the corresponding reduction in contract-related activities.

 

Nine months ended September 30, 2026 vs 2025

 

Cost of revenue for the nine months ended September 30, 2026, was $3,252,996, compared to $3,606,520 for the corresponding period in 2025, representing a decrease of $353,524, or 9.8%. The decrease primarily reflects lower contract cost of revenue resulting from the completion of the Company's development program. This decrease was partially offset by higher HEXWAVE™ cost of revenue as additional inventory associated with customer deliveries was recognized during the period.

 

During the nine months ended September 30, 2026, contract cost of revenue was $851,124, compared to contract revenue of $357,759, resulting in a gross loss of $493,365 from contract activities.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 9

 

 

iii)Engineering and Research & Development

 

Three months ended September 30, 2026 vs 2025

 

Engineering and research and development expenses for the three months ended September 30, 2026, were $1,166,284, compared to $668,780, for the three months ended September 30, 2025, representing an increase of $497,504 or 74.4%. The increase was mainly attributable to higher office, rent and administration, product development, travel and miscellaneous expenses, increased depreciation expense and higher salaries and consulting fees.

 

During the three months ended September 30, 2026, engineering and research and development expenses included $178,029 in product development and technology costs, $550,420 in salaries and consulting fees, $327,056 of office, rent and administration, travel and miscellaneous expenses, and $110,779 of depreciation expense.

 

Nine months ended September 30, 2026 vs 2025

 

Engineering and research and development expenses for the nine months ended September 30, 2026 were $2,859,198, compared to $2,058,666 for the corresponding period in 2025, representing an increase of $800,532, or 38.9%. The increase was primarily attributable to higher office, rent and administration, travel and miscellaneous expenses, which increased by $610,645 compared to the prior period, as well as increased depreciation expense and higher product development and technology costs. These increases were partially offset by lower salaries and consulting fees and the absence of stock-based compensation expense during the current period.

 

Engineering and research and development expenses for the nine months ended September 30, 2026 consisted of $1,516,035 in salaries and consulting fees, $373,301 in product development and technology costs, $657,920 in office, rent and administration, travel and miscellaneous expenses, and $311,942 in depreciation expense.

 

iv)General, Administrative and Corporate Expenses

 

Three months ended September 30, 2026 vs 2025

 

General and administrative expenses for the three months ended September 30, 2026 were $1,518,586, compared to $1,196,771 for the corresponding period in 2025, representing an increase of $321,815, or 27%. The increase was primarily attributable to higher salaries and consulting fees and legal and professional fees, partially offset by lower general and administrative expenses and reduced stock-based compensation compared to the corresponding period in 2025.

 

General and administrative expenses for the three months ended September 30, 2026 consisted of $438,518 in office, rent and administration, travel and miscellaneous expenses, $131,571 in legal and professional fees, $817,165 in salaries and consulting fees, and $131,332 in stock-based compensation.

 

Nine months ended September 30, 2026 vs 2025

 

General and administrative expenses for the nine months ended September 30, 2026 were $4,735,539, compared to $6,101,438 for the corresponding period in 2025, representing a decrease of $1,365,899, or 22%. The decrease was primarily attributable to lower office, rent and administration, travel and miscellaneous expenses, reduced stock-based compensation, and lower legal and professional fees, partially offset by higher salaries and consulting fees compared to the corresponding period in 2025.

 

General and administrative expenses for the nine months ended September 30, 2026 consisted of $2,053,759 in office, rent and administration, travel and miscellaneous expenses, $1,495,010 in salaries and consulting fees, $712,400 in legal and professional fees, and $474,370 in stock-based compensation.

 

v)Other Income (Expenses)

 

Three months ended September 30, 2026 vs 2025

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 10

 

 

Other income, net for the three months ended September 30, 2026 was $10,152, compared to other income of $3,341 for the corresponding period in 2025. The increase was primarily attributable to higher interest income compared to prior period.

 

Interest expense for the three months ended September 30, 2026 decreased to $33,649, compared to $142,966 for the corresponding period in 2025, primarily reflecting lower interest incurred on the Company's debt facilities following their repayment.

 

The Company recorded a foreign exchange loss of $8,686 during the three months ended September 30, 2026, compared to a foreign exchange loss of $8,597 during the corresponding period in 2025, primarily reflecting fluctuations in foreign exchange rates affecting monetary assets and liabilities denominated in foreign currencies. Additionally, the Company recognized a non-cash gain of $171,919 from changes in the fair value of derivative warrant liabilities, compared to $nil in the corresponding period in 2025.

 

Nine months ended September 30, 2026 vs 2025

 

Net other income for the nine months ended September 30, 2026, was $1,266,791, compared to net other expense of $507,838 for the corresponding period in 2025. The increase was primarily attributable to a $1.58 million non-cash gain recognized on the initial recognition of a derivative warrant liability following the parent company's change in functional currency from the Canadian dollar ("CAD") to the U.S. dollar ("USD"). As a result of the change in functional currency, certain outstanding CAD-denominated warrants no longer qualified for equity classification under IAS 32 and were reclassified as derivative financial liabilities. Refer to Notes 3 and 15 to the condensed consolidated interim financial statements for further details.

 

Interest expense for the nine months ended September 30, 2026 decreased to $404,901, compared to $483,898 for the corresponding period in 2025, primarily reflecting changes in interest incurred on the Company's outstanding debt facilities during the period.

 

The Company recorded a foreign exchange gain of $8,370 during the nine months ended September 30, 2026, compared to a foreign exchange loss of $28,611 during the corresponding period in 2025, primarily reflects the impact of foreign currency fluctuations on the Company's monetary assets and liabilities denominated in foreign currencies during the period.

 

3.Summary of Quarterly Results

 

Three months ended  Working capital
(deficiency)
   Total assets   Total loss and
comprehensive
income loss
   Loss per share 
   $   $   $   $ 
30-Sep-26   4,344,100    9,353,496    (2,970,187)   (0.46)
30-Jun-26   7,211,894    13,479,695    (2,230,946)   (0.43)
31-Mar-26   (6,579,966)   5,339,690    (2,697,469)   (1.38)
31-Dec-25   (4,902,610)   6,384,615    (3,526,571)   (2.15)
30-Sep-25   (4,452,151)   6,754,164    (3,097,554)   (2.03)
30-Jun-25   (4,447,549)   6,352,896    (3,677,596)   (3.25)
31-Mar-25   (650,555)   8,522,470    (3,629,323)   (3.49)
31-Dec-24   (2,652,516)   7,286,501    (2,336,807)   (5.40)

 

Discussion of Quarterly Trends

 

Q3 2026 (September 30, 2026):

 

Net loss and comprehensive loss for the three months ended September 30, 2026 was $2.97 million, or $0.46 per share, compared to a net loss of $3.01 million, or $2.03 per share, for the corresponding period in 2025. During the quarter, the Company continued its efforts related to the production of HEXWAVE™ units and the completion of its TSA-related programs. The Company also continued to invest in inventory procurement, customer demonstrations and industry trade shows to support future commercial growth.

  

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 11

 

 

Q2 2026 (June 30, 2026):

 

The Company's common shares commenced trading on Nasdaq on April 22, 2026, and the Company completed its initial public offering on April 23, 2026, significantly strengthening its financial position. As a result, working capital improved from a deficiency of $6.6 million at March 31, 2026, to positive working capital of $7.2 million at June 30, 2026. In addition, the quarter included a significant non-cash gain resulting from the initial recognition of derivative warrant liabilities following the Company's change in functional currency from the Canadian dollar to the U.S. dollar.

 

Q1 2026 (March 31, 2026):

 

Net loss and comprehensive loss for the three months ended March 31, 2026, was $2.7 million, or loss per share of $1.38. During the quarter, the Company continued its efforts related to the production of the HEXWAVE™ units and the completion of the TSA related programs, resulting in revenue of $919,421. In addition, the Company incurred costs associated with the financing and uplisting activities completed subsequent to the quarter end, while continuing to invest in marketing initiatives, trade shows, and customer demonstrations intended to support future commercial growth.

 

Q4 2025 (December 31, 2025):

 

Net loss and comprehensive loss was $3.5 million (loss per share of $2.15). During the quarter, the Company continued production of HEXWAVE™ however, no shipments occurred. Backlog orders continued, however customers preferred shipment during Q1 - 2026. Marketing and investor relations efforts also continued to increase to support sales initiatives. The working capital deficiency increased slightly to $4.9 million. The Company also closed a private placement on December 31, 2025, generating gross proceeds of $1.3 million.

 

Q3 2025 (September 30, 2025):

 

Net loss and comprehensive loss was $3.0 million (loss per share of $2.03). During the quarter, the Company continued production of HEXWAVE™ while advancing research and development on other licensed technologies. HEXWAVE™ shipments continued, with TSA contract performance remaining on schedule. Marketing and investor relations efforts also increased to support sales initiatives. The working capital deficiency remained flat at $4.4 million. The Company also closed a private placement on July 29, 2025, generating gross proceeds of $3.2 million.

 

Q2 2025 (June 30, 2025):

 

Net loss and comprehensive loss was $3.7 million (loss per share of $3.25). During the quarter, the Company continued production of HEXWAVE™ while advancing research and development on other licensed technologies. HEXWAVE™ shipments continued, with TSA contract performance remaining on schedule. Marketing and investor relations efforts also increased to support sales initiatives. The working capital deficiency increased to $4.4 million, reflecting continued cash usage in operations.

 

Q1 2025 (March 31, 2025):

 

Net loss and comprehensive loss was $3.6 million (loss per share of $3.49). The Company closed a private placement on March 20, 2025, generating gross proceeds of $3.48 million, which increased total assets to $8.5 million. The results also reflected higher operating expenses associated with commercialization activities.

 

Q4 2024 (December 31, 2024):

 

Net loss and comprehensive loss for the quarter was approximately $2.3 million, with a loss per share of $5.40. The results primarily reflected ongoing investment in HEXWAVE™ production and commercialization, research and development on licensed technologies, stock-based compensation, and financing-related expenses. A detailed discussion of this quarter was provided in the Company's MD&A for the corresponding period, available on SEDAR+.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 12

 

  

Overall Trends

 

The Company has incurred net losses over the past eight quarters as it has continued to invest in the development and commercialization of its HEXWAVE™ technology and related products. Quarterly operating results have been influenced by the timing of product deliveries and contract revenue recognition, fluctuations in research and development and general and administrative expenses, including stock-based compensation, and costs associated with commercialization, marketing and financing activities.

 

During this period, the Company strengthened its financial position through a series of financing transactions, culminating in the successful completion of its initial public offering and Nasdaq listing in April 2026. These financings have significantly improved the Company's liquidity and working capital position, enabling increased investment in inventory, production capacity and commercialization activities to support future growth.

 

4.Liquidity and Capital Resources

 

(a) Liquidity

 

As of September 30, 2026, the Company maintained a cash balance of $3,720,790 and experienced a working capital of $4,344,100. Current liabilities amounted to $2,986,985 as of the same date, primarily attributed to expenses associated with commencing production, ongoing development of the Company’s licensed technologies, and maintaining licenses and the Company’s public registry in good standing.

 

   Nine Months Ended September 30, 
   2026   2025 
Cash (used in) provided by:          
           
Operating activities:          
Net loss for the period  $(7,898,603)  $(10,510,206)
Items not involving cash:   84,850    2,520,479 
Changes in non-cash working capital:   (3,413,353)   (390,169)
Cash used in operating activities   (11,227,106)   (8,379,896)
           
Cash used in investing activities   –    (176,498)
           
Cash provided by financing activities   14,776,656    7,931,412 
           
Effect of foreign exchange rate changes on cash   (148,054)   112,660 
           
Increase (Decrease) in cash   3,401,496    (512,322)
           
Cash, beginning of the period   319,294    1,153,229 
           
Cash, end of the period  $3,720,790   $640,907 

 

During the nine months ended September 30, 2026, the Company used $11,227,106 of cash in operating activities, compared to $8,379,896 during the corresponding period in 2025. The increase in cash used in operating activities was primarily attributable to unfavorable changes in non-cash working capital, partially offset by a lower net loss during the period.

 

Non-cash items primarily included stock-based compensation, depreciation and amortization, inventory impairment, accrued interest, credit line fees, the recognition of previously capitalized contract costs in cost of revenue upon completion of the related performance obligation, and the non-cash gain recognized on the initial recognition of derivative warrant liabilities following the Company's change in functional currency.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 13

 

 

 

Changes in non-cash working capital used $3,413,353 of cash during the nine months ended September 30, 2026, compared to cash used of $390,169 during the corresponding period in 2025. The increase in working capital outflows was primarily attributable to increases in accounts receivable, prepaid expenses and inventory, together with a reduction in accounts payable and accrued liabilities. These changes were partially offset by an increase in deferred revenue.

 

The increase in working capital outflows during the period was primarily driven by inventory purchases to support commercialization activities and the settlement of outstanding accounts payable and accrued liabilities.

 

Operating cash flows for the nine months ended September 30, 2026, and 2025 reflect the Company's continued investment in research and development, commercialization initiatives and general and administrative activities, including salaries, consulting fees, investor relations and promotional activities.

 

Cash used in investing activities during the nine months ended September 30, 2026, was $nil, compared to $176,498 during the corresponding period in 2025. The cash outflows primarily related to purchases of property and equipment. Investing cash outflows were higher than in the prior year period due to increased capital expenditures.

 

Net cash provided by financing activities during the nine months ended September 30, 2026, was $14,776,656, compared to $7,931,412 during the corresponding period in 2025. Financing activities during the current period primarily consisted of:

 

·net proceeds of $18,645,715 from equity issuances, including the Company's initial public offering and January 2026 private placement, net of share issuance costs;

·proceeds of $2,754,192 from the Parabilis factoring and credit line;

·partially offset by repayments of $2,766,121 on the Parabilis term loan, $3,638,578 under the factoring facility, and $218,552 of lease liabilities.

 

No proceeds were received from the exercise of warrants during the nine months ended September 30, 2026, compared to proceeds of $2,075,555 during the corresponding period in 2025.

 

During the corresponding period in 2025, financing activities primarily reflected net proceeds of $6,120,797 from private placements and $2,075,555 from the exercise of warrants, $650,000 from proceeds from Parabilis Loan, and $350,000 from the Parabilis factoring and credit line facility. These proceeds were partially offset by repayments of $100,908 in working capital loans, $1,023,267 under the Parabilis term loan and credit line facilities, and $140,765 in lease liabilities.

 

Dividends

 

The Company has not declared or paid dividends to date and has no current plans to do so in the foreseeable future.

 

Contractual Obligations

 

As at September 30, 2026, the Company had accounts payable and accrued liabilities of $2,415,851, all classified as current liabilities. The Company also had lease liabilities totaling $353,562, comprising $245,389 in current liabilities and $108,173 in non-current liabilities.

 

The Company had deferred revenue of $325,745, representing amounts received or billed in advance of satisfying its performance obligations to customers.

 

In addition, the Company had a derivative warrant liability of $25,018, measured at fair value. This liability does not necessarily represent a contractual cash payment obligation.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 14

 

 

The Company's contractual lease payment obligations are disclosed in Note 12 to the condensed interim consolidated financial statements.

 

In addition to the obligations described above, the Company has ongoing minimum annual payment commitments under its technology licensing agreements with MIT and Battelle Memorial Institute, as described in Section 1(c) of this MD&A and Note 8 to the condensed interim consolidated financial statements. These commitments are subject to the terms of the respective agreements and represent additional considerations in the Company's assessment of future liquidity requirements.

 

(b) Capital Transactions and Resources

 

Common share transactions for the nine months ended September 30, 2026

 

i)On January 15, 2026, the Company closed the second and final tranche of the December 2025 non-brokered private placement for additional gross proceeds of $624,002 (CAD$867,506) through the issuance of 87,626 units at a price of CAD$9.90 per unit. Each unit comprised one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share at an exercise price of CAD$13.50 per share, exercisable from March 17, 2026, to January 15, 2028. The warrants were allocated a residual value of $56,452. In connection with the private placement, the Company issued an aggregate of 5,045 broker warrants to agents under terms and conditions substantially identical to those of the unit warrant. The broker warrants were allocated a fair value of $13,087 (CAD$18,194). Additionally, the Company paid commissions and legal expenses of $48,490 (CAD$67,413).

 

  ii)On April 21, 2026, the Company priced an initial public offering in the United States consisting of 3,673,638 common shares at a price of $4.50 per share for gross proceeds of $16,531,371 and, in lieu of common shares for certain investors, 770,807 pre-funded warrants at a purchase price of $4.4999 per pre-funded warrant for gross proceeds of $3,468,554. The common shares commenced trading on the Nasdaq Capital Market on April 22, 2026, under the symbol "DETX". The offering closed on April 23, 2026, resulting in aggregate gross proceeds of $19,999,925. The Company incurred commissions and legal expenses of $2,733,420 in connection with the offering, of which $2,259,367 was allocated to the common shares and $454,053 was allocated to the pre-funded warrants.
    
   The pre-funded warrants were classified as equity instruments in accordance with IAS 32, Financial Instruments: Presentation, as they represent the right to acquire a fixed number of the Company's common shares for a fixed exercise price denominated in the Company's functional currency at the date of issuance. The gross proceeds received from the issuance of the pre-funded warrants were recorded within equity reserves and will be transferred to share capital upon exercise. As equity instruments, the pre-funded warrants are not subsequently remeasured.

 

iii)On July 24, 2026, the Company settled a total of $82,485 (CAD$117,000) of indebtedness with a certain creditor by issuing 23,306 shares valued at $82,485. The settlement was a non-cash financing transaction.

 

iv)On July 29, 2026, a total of 340,121 share purchase warrants expired with an exercise price of CAD$15.75. The related warrant reserve balance of $45,209 was reclassified to share capital.

 

v)On March 13, 2026, the Company completed a consolidation of its issued and outstanding common shares on the basis of one post-consolidation common share for every 45 pre-consolidation common shares. The consolidation was approved by shareholders on February 6, 2026. The number of common shares issuable upon exercise of outstanding stock options and warrants and their respective exercise prices were adjusted proportionately. All historical share and per-share information presented in this MD&A has been adjusted retrospectively, where applicable, to reflect the consolidation.

 

vi)During the nine months ended September 30, 2026, a total of 736 common shares were issued pursuant to the RSUs with a fair value of $59,797.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 15

 

 

Common share transactions for the year ended December 31, 2025

 

i)On January 6, 2025, the Company received $2,071,851 (CAD$2,977,851) from the exercise of 120,317 share purchase warrants after electing, on December 31, 2024, to exercise its acceleration right for a total of 277,778 warrants granted on December 19, 2024, pursuant to a private placement. As a result, the remaining 157,461 unexercised warrants expired.

  

ii)On March 20, 2025, the Company closed a non-brokered private placement for gross proceeds of $3,479,351 (CAD$5,001,183). The Company issued 67,356 units (each a “Unit”) of the Company at a price of CAD$74.25 per Unit. Each Unit comprised of one common share and one-half common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the Company at a price of CAD$92.25 for a period of 24 months and is subject to an accelerated expiry at the Company’s election under certain conditions. The warrants were allocated a residual value of $263,584. In connection with the non-brokered private placement, the Company issued 4,715 finder warrants. Each finder’s warrant will be exercisable to purchase one common share for a period of 24 months at an exercise price of CAD$74.25. The broker warrants were allocated a fair value of $84,183 (CAD$121,004). Additionally, the Company paid commissions and legal expenses of $420,424 (CAD$600,650).

 

iii)On April 1, 2025, a total of 78 shares were issued pursuant to the exercise of 78 warrants, resulting in proceeds of $3,704 (CAD$5,285). Residual value in the amount of $nil was reversed.

 

iv)On April 13, 2025, a total of 478 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $5,498 and the reverse value was reclassified to share capital.

 

v)On May 9, 2025, a total of 309 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $3,816 and the reverse value was reclassified to share capital.

 

vi)On June 6, 2025, a total of 206 finder warrants expired with an exercise price of $135.00. These broker warrants had a fair value of $1,892 and the reverse value was reclassified to share capital

 

vii)On July 29, 2025, the Company closed a non-brokered private placement for gross proceeds of $3,199,767 (CAD$4,399,996). The Company issued 444,444 units (each a “Unit”) of the Company at a price of CAD$9.90 per Unit. Each Unit comprised of one common share and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the Company at a price of CAD$15.75 for a period of 12 months and is subject to an accelerated expiry at the Company’s election under certain conditions. The warrants were allocated a residual value of $nil. Additionally, the Company issued 16,000 broker warrants with a fair value of $38,472 (CAD$52,902). The Company paid commissions and legal expenses of $137,898 (CAD$189,781).

 

viii)On October 31, 2025, the Company received gross proceeds of $1,353,116 (CAD$1,895,093) from the exercise of 120,323 warrants.

 

ix)On December 31, 2025, the Company closed the first tranche of a non-brokered private placement for gross proceeds of $1,274,365 (CAD$1,747,172), through the issuance of 176,482 units at a price of CAD$9.90 per unit. Each unit comprised one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share at an exercise price of CAD$13.50 per share, exercisable from March 2, 2026, to December 31, 2027. The Company issued an aggregate of 7,915 broker warrants with a fair value of $20,866 (CAD$28,608). The warrants were allocated a residual value of $115,851 (CAD$158,833). The Company paid commissions and legal expenses of $57,331 (CAD$78,356).

 

x)During the year ended December 31, 2025, a total of 4,758 common shares were issued pursuant to the RSUs with a fair value of $383,471.

 

Other sources of funds:

 

Other sources of funds potentially available to the Company are through the exercise of outstanding stock options and share purchase warrants with the following. However, the exercise of these instruments is dependent on prevailing market conditions and the decisions of individual holders, and there can be no assurance that the Company will receive material proceeds from such exercises.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 16

 

 

On June 2, 2025, the Company obtained conditional approval from the TSX Venture Exchange to undertake a normal course issuer bid (the “NCIB”) to purchase up to 5,142,844 of its outstanding Common Shares (pre-consolidation) (114,285 post-consolidation), representing approximately 10% of the Company’s public float. The NCIB commenced on June 5, 2025, and expired on June 4, 2026. The Company engaged Research Capital to act as its broker for purchases under the NCIB. Any shares purchased pursuant to the NCIB would have been returned to treasury and cancelled; however, no Common Shares were repurchased under the NCIB prior to its expiry.

 

As at September 30, 2026, the number of stock options outstanding and exercisable was:

 

   Outstanding   Exercisable 
Expiry date  Number of stock
options
   Exercise price   Remaining
contractual life
(years)
   Number of stock
options
 
1-Nov-26   944   CAD$207.00    0.09    944 
14-Jan-27   222   CAD$162.00    0.29    222 
15-Apr-27   1,111   CAD $26.55    0.54    1,111 
26-Apr-27   2,633   CAD$184.50    0.57    2,633 
2-Jul-27   5,556   CAD$10.80    0.75    5,556 
21-Nov-27   133   CAD$99.00    1.14    133 
26-Apr-28   111   CAD $81.00    1.57    111 
16-Oct-28   1,778   CAD $85.50    2.05    1,778 
30-Dec-29   51,667   CAD $38.25    3.25    46,181 
2-Apr-30   3,333   CAD $37.80    3.51    2,083 
30-Sep-30   41,111   CAD $12.15    4.00    41,111 
September 30, 2026   108,599              101,863 

 

During the nine months ended September 30, 2026, the Company recognized stock-based compensation related to stock options totaling $300,793 (September 30, 2025 – $1,032,541). Of this amount, $10,191 was recorded as stock-based compensation in the HEXWAVE™ cost of revenue (September 30, 2025 – $13,747), and $10,264 was recorded as stock-based compensation in cost of contract revenue (September 30, 2025 - $2,765).

 

As at September 30, 2026, the number of restricted share units (“RSUs”) outstanding was 331,900, of which 5,863 were vested. The outstanding RSUs are summarized in the following table:

 

   Number of
equity settled
RSUs
   Grant Price 
Outstanding, December 31, 2024   11,918   CAD$ 180.45 
Granted   8,260   10.91 
Exercised   (4,758)  115.88 
Outstanding December 31, 2025   15,420   CAD$ 55.51 
Exercised   (736)  113.13 
Cancelled   (1,672)  178.89 
Granted   318,888   2.97 
Outstanding, September 30, 2026   331,900   CAD$ 4.28 

 

The estimated fair value of the equity settled RSUs granted as of September 30, 2026, was $670,573 (December 31, 2025 - $60,998) and will be recognized as an expense over the vesting period of the RSUs. The fair value of the equity settled RSUs as at the grant date was determined with reference to the market value of the common shares of the Company at the grant date.

 

During the nine months ended September 30, 2026, the Company recognized stock-based compensation related to RSUs in the amount of $130,154 (September 30, 2025 – $25,017).

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 17

 

 

Restricted share units granted for the nine months ended September 30, 2026:

 

i)On September 24, 2026, the Company granted 23,888 RSUs to board members; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 24, 2031, and vests 100% on September 24, 2027.

  

ii)On September 24, 2026, the Company granted 255,000 RSUs to employees; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 24, 2031, and vests 100% on September 24, 2027.

 

iii)On September 30, 2026, the Company granted 40,000 RSUs to an employee; these RSUs shall be settled with common shares of the Company, have an exercise period that expires September 30, 2031, and vests 100% on September 30, 2027.

 

During the year ended December 31, 2025, the following transactions occurred in connection to restricted share units:

 

i)During the year ended December 31, 2025, a total of 4,758 common shares were issued pursuant to the exercise of RSUs.

 

ii)On August 7, 2025, the Company granted 1,111 RSUs to consultants; these RSUs shall be settled with common shares of the Company, have an exercise period that expires on January 1, 2029, and vest at 100% on January 1, 2026.

 

iii)On December 12, 2025, the Company granted 7,149 RSUs to a contractor; these RSUs shall be settled with common shares of the Company, have an exercise period that expires December 12, 2029, and vests 100% on December 12, 2026.

 

As at September 30, 2026, the outstanding number of share purchase warrants are as follows:

 

   Warrants   Exercise 
   outstanding   Price 
Outstanding, December 31, 2024   446,109   CAD$ 54.90 
Issued   683,234   19.32 
Expired   (169,855)  32.79 
Exercised   (240,718)  20.27 
Outstanding December 31, 2025   718,770   CAD$ 36.45 
Issued   92,672   13.50 
Expired   (340,121)  15.75 
Outstanding September 30, 2026   471,321   CAD$ 47.76 

 

Effective April 23, 2026, certain outstanding CAD-denominated warrants were reclassified from equity to derivative financial liabilities following the Company's change in functional currency. Refer to notes 3 and 15. The pre-funded warrants issued in connection with the Company's initial public offering are not included in the above reclassification, as they continue to qualify for equity classification under IAS 32. As at September 30, 2026, the Company had 770,807 pre-funded warrants outstanding (December 31, 2025 – nil). Each pre-funded warrant entitles the holder to acquire one common share of the Company at an exercise price of $0.0001 per share and remains exercisable until exercised. As equity instruments, the pre-funded warrants are not subsequently remeasured.

 

(c) Performance Shares

 

On March 17, 2021, Liberty deposited into escrow, and held in escrow, Operational Performance Shares (“OPS”) and Capital Market Performance Shares (“CMPS”) for certain directors, officers, and consultants of the Company upon the Company achieving certain performance milestones. Once these milestones were achieved the shares would be released. These performance shares included 4,444 of OPS and 19,496 of CMPS. In order to fair value these performance shares, management estimated the probability that the Company would issue the performance shares.

 

All CMPS have been issued in previous years upon the completion of all required milestones.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 18

 

 

Operational Performance Shares

 

As at September 30, 2026, none of the 4,444 OPS have been released from escrow. The Company continues to assess the achievement of the applicable performance milestones. The estimated fair value of the OPS is CAD$800,000, with an estimated vesting period ending in March 2027. During the nine months ended September 30, 2026, the Company recorded stock-based compensation related to OPS of $63,880 (nine months ended September 30, 2025 – $77,727). For the nine months ended September 30, 2026, and 2025, none of the OPS were released from escrow.

 

(a)Reconciliation of use of proceeds from the Initial Public Offering (April 2026) (“IPO Q2 2026”)

 

Intended use of proceeds of IPO Q2 2026  Actual use of proceeds
from IPO Q2 2026
   (Over)/under
expenditure
   Explanation of
Variance and
impact on
business objectives
Agent’s fees and expenses  $1,777,344   $1,777,344   $-   N/A
Legal Fees associated with Nasdaq uplisting  $2,733,450   $2,733,450   $-   N/A
Payable and Loans  $4,758,137   $4,758,137   $-   N/A
Marketing and Investor Relations  $500,000   $315,065   $184,935   Balance to be used for planed trade shows and marketing initiatives
General and Administrative Expenses  $4,230,994   $3,332,244   $898,750   Balance to be used for future G&A expenses
Further the production of HEXWAVE™ and HD-AIT to support the increase in demand and deliver units in backlog to customers  $6,000,000   $3,362,895   $2,637,105   Balance to be used for HEXWAVE™ support and production.
Total  $19,999,925   $16,279,135   $3,720,790   N/A

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 19

 

 

(b)Reconciliation of use of proceeds from the non-brokered private placement closed on January 15, 2026 (“PP Q1 2026”)

 

Intended use of proceeds of PP Q1 2026  Actual use of proceeds
from PP Q1 2026
   (Over)/under
expenditure
   Explanation of
Variance and
impact on
business objectives
Agent’s legal fees, expenses and disbursements  $21,225   $21,225   $-   N/A
Cash portion of Agent’s corporate finance fee  $36,027   $36,027   $-   N/A
Further the production of HEXWAVE™ to support the increase in demand and deliver units in backlog to customers  $566,750   $566,750   $-   N/A
Total  $624,002   $624,002   $                        -   N/A

 

(c)Reconciliation of use of proceeds from the non-brokered private placement closed on December 31, 2025 (“PP Q4 2025”)

 

Intended use of proceeds of PP Q4 2025  Actual use of proceeds
from PP Q4 2025
   (Over)/under
expenditure
   Explanation of
Variance and
impact on
business objectives
Cash portion of Agent’s corporate finance fee  $56,029   $56,029   $-   N/A
Further the production of HEXWAVE™ to support the increase in demand and deliver units in backlog to customers  $1,274,365   $1,274,365   $-   N/A
Total  $1,330,394   $1,330,394   $                        -   N/A

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 20

 

 

d)Reconciliation of use of proceeds from the non-brokered private placement closed on July 29, 2025 (“PP Q3 2025”)

 

PP Q3 2025Intended use of proceeds of PP Q3 2025  Actual use of
proceeds
from PP Q3 2025
   (Over)/under
expenditure
   Explanation of
Variance and
impact on
business objectives
Agent’s legal fees, expenses and disbursements  $21,043   $21,043   $-   N/A
Cash portion of Agent’s corporate finance fee  $115,187   $115,187   $-   N/A
Consulting and Investor Relations from Private Placement  $1,150,000   $1,150,000   $-   N/A
Further the production of HEXWAVE™ to support the increase in demand and deliver units in backlog to customers  $1,913,537   $1,913,537   $-   N/A
Total  $3,199,767   $3,199,767   $                        -   N/A

 

(e)Reconciliation of use of proceeds from the non-brokered private placement closed on March 20, 2025 (“PP Q1 2025”)

 

Intended use of proceeds of PP Q1 2025  Actual use of
proceeds
from PP Q1 2025
   (Over)/under
expenditure
   Explanation of
Variance and
impact on
business objectives
Agent’s legal fees, expenses and disbursements  $78,790   $78,790   $-   N/A
Cash portion of Agent’s corporate finance fee  $243,555   $243,555   $-   N/A
Consulting and Investor Relations from Private Placement  $498,374   $498,374   $-   N/A
Further the production of HEXWAVE™ to support the increase in demand and deliver units in backlog to customers  $2,658,632   $2,658,632   $-   N/A
Total  $3,479,351   $3,479,351   $                        -   N/A

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 21

 

 

5.Commitments

 

i)As at September 30, 2026, and December 31, 2025, the minimum lease payments are as follows:

 

   September 30,   December 31, 
   2026   2025 
Maturity analysis - contractual undiscounted cash flows          
One year or less  $245,387   $238,567 
Two to five years   133,579    358,949 
Six years and thereafter   -    - 
Total lease liabilities  $378,966   $597,516 
Lease liabilities included in the statement of financial position  $353,562   $536,235 
Current  $245,389   $235,834 
Non-current  $108,173   $300,401 

 

6.Revenue

 

Revenue recognized for the three and nine months ended September 30, 2026, and 2025, relates to contract revenue from the Transportation Security Administration (“TSA”), as well as sales of HEXWAVE™ units.

 

   Three months ended September 30,   Nine months ended September 30, 
Revenue  2026   2025   2026   2025 
TSA Contract Award HD-AIT   -    -    -    457,905 
TSA OA Development   -    -    -    246,944 
HD-AIT Phase II A   -    150,000    -    150,000 
HD-AIT Phase II B   82,759    -    357,759    - 
HEXWAVE units   618,462    129,049    1,220,390    861,500 
HEXWAVE Software, Training & Warranty, Interest   19,496    -    104,190    47,907 
Total Revenue  $720,717   $279,049   $1,682,339   $1,764,256 

 

As of September 30, 2026, the Company continued its efforts to achieve revenue growth, supported by a HEXWAVE™ order backlog of approximately $955,000.

 

During the nine months ended September 30, 2026, the Company delivered 13 HEXWAVE™ units at an average selling price per unit of approximately US$93,876, compared to 12 units delivered at an average selling price per unit of approximately US$71,792 during the nine months ended September 30, 2025. The higher volume of deliveries in the current period, was primarily attributable to management’s focus on manufacturing optimization and operational efficiency initiatives during the period.

 

Future revenue for the Company consists of HEXWAVE™ purchasers, existing and expected additional Transportation Security Administration (“TSA”) contract revenue and other sources. For the nine months ended September 30, 2026, the Company recorded total revenue of $1,764,256, primarily from HEXWAVE™ sales and TSA contract revenue. The timing and amount of future revenue recognized will depend on customer deployment schedules, delivery, acceptance and other factors, including customer procurement decisions, government budget approvals and funding availability, and the successful execution of existing and anticipated contracts.

 

During the nine months ended September 30, 2026, revenue from three significant HEXWAVE™ customers totaled $825,000, representing approximately 61% of HEXWAVE™ revenue. As the Company continues its commercialization efforts, revenue may fluctuate depending on the timing and volume of purchases by individual customers. The Company continues to pursue opportunities to expand and diversify its customer base.

 

Backlog Orders

 

The Company has shipped a total of $1,180,000 of HEXWAVE™ backlog orders, with $955,000 of backlog remaining as at September 30, 2026. Following the increase in production capacity, the Company continues to work toward fulfilling the remaining backlog, subject to production schedules, inventory availability and customer delivery requirements. Historically, the Company experienced inventory constraints due to limited funding. During the period, however, the Company secured additional financing, which supported inventory availability and the fulfillment of customer orders.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 22

 

  

HEXWAVE™ Sales Opportunities

 

As a relatively new product with limited historical sales data and few comparable market benchmarks, the timing and volume of future HEXWAVE™ sales remain uncertain. The Company has received several requests for quotations and proposals from prospective customers that represents potential future sales opportunities. Historically, limited funding constrained the Company's ability to pursue sales opportunities, invest in marketing initiatives, and promote the HEXWAVE™ product, which may have delayed its market visibility and customer adoption. During the period, however, the Company secured additional financing to support these activities. The Company continues to pursue additional customer orders as production capacity increases and market adoption progresses.

 

TSA Contract Revenue:

 

The Company has experienced delays in TSA contract revenue projects, as well as in additional contract line items that the TSA had planned to exercise in 2025 and 2026. As of September 30, 2026, revenue of $357,759 was recognized and the current contract project has been completed.

 

Global Economic Challenges:

 

The Company continues to operate in a challenging global economic environment, characterized by constrained capital markets and slower customer procurement cycles. These conditions, which began in 2024, have persisted through 2025 and early 2026 and continue to affect the timing of purchase orders for HEXWAVE™ units.

 

While interest rates remain elevated, recent signals of potential monetary policy easing in 2026 may improve access to capital markets and support increased customer activity. Management expects that any improvement in financing conditions could positively impact order volumes in future periods.

 

In response, the Company has undertaken proactive measures to mitigate these challenges and position itself for growth. These include:

 

·Increasing product awareness through targeted marketing and investor relations activities;

·Focusing on advancing customer pilots and demonstrations to strengthen the sales pipeline; and

·Maintaining operational readiness to scale production as purchase commitments are secured.

 

Management also recognizes that current capital market conditions directly affect the Company’s liquidity and working capital position. As at September 30, 2026, the Company had a working capital of $4.3 million. The Company continues to have significant operating and working capital requirements, as discussed in the Liquidity and Contractual Obligations sections of this MD&A. Continued access to external financing will therefore be critical to support operations and growth initiatives until the Company is able to generate sufficient cash flows from commercial activities.

 

7.Contract Awards

 

During the nine months ended September 30, 2026, the Company recognized total contract revenue of $357,759 (September 30, 2025 - $854,849). As of September 30, 2026, the Company had completed the performance obligations under its existing TSA development contract, and no additional revenue is currently expected from this contract.

 

TSA HD-AIT Phase II B

 

On September 29, 2025, the Company received a contract award for $357,759 from TSA for the HD-AIT Phase II B option. The contract award is a follow-on option to the current HD-AIT development program to execute phase II to drive to a final hardware design capable of supporting future compliance efforts. Under the agreement, invoices are issued upon achievement of the contractual milestones in accordance with the agreed timeline. As at September 30, 2026, all contractual milestones have been completed, and the Company had received payments of $275,000 with the remaining $82,759 (September 30, 2025 - $nil) recorded as trade accounts receivable.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 23

 

 

 

 

TSA HD-AIT Phase II B  Amounts 
Year 2026     
Milestone 3 (Q1 2026)  $100,000 
Milestone 4 (Q1 2026)   175,000 
Milestone 5 (Q3 2026) (receivable)   82,759 
Total Contract Value  $357,759 

 

As of September 30, 2026, the Company recorded contract costs of $nil representing costs incurred for contract milestones not yet achieved less related impairment charges (December 31, 2025 - $152,421).

 

8.Off-balance Sheet Arrangements

 

The Company does not utilize off-balance sheet arrangements.

 

9.Transactions Between Related Parties

 

Compensation of key management personnel:

 

Key management personnel include persons having the authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The key management personnel of the Company are the members of the Company’s executive management team and Board of Directors. Compensation provided to key management personnel is as follows:

 

   Three months ended September 30,   Nine months ended September 30, 
   2026   2025   2026   2025 
Salaries  $291,846   $385,401   $1,114,511   $1,061,266 
Stock-based compensation   101,683    166,095    271,540    693,419 
   $393,529   $551,496   $1,386,051   $1,754,685 

 

As of September 30, 2026, the Company had a balance payable of $357,146 to key management personnel (December 31, 2025, – $434,831). This payable balance includes accounts payable and accrued liabilities relating to compensation to directors, officers, or their related companies, included in compensation of key management personnel. These related party balances are unsecured, non-interest bearing and have no specific terms of settlement.

 

During the nine months ended September 30, 2026, the Company received $327,046 in working capital loans (September 30, 2025 - $nil) from members of key management personnel or their related parties and repaid $327,046 (September 30, 2025 - $74,658). As at September 30, 2026, the outstanding balance is $nil (December 31, 2025 – $nil). Refer to Note 9(a) of the condensed interim consolidated financial statements.

 

10.Subsequent Events

 

Subsequent to September 30, 2026, the Company recorded:

 

·On October 5, 2026, a total of 40,966 share purchase warrants expired without being exercised.

 

·On October 29, 2026, a total of 1,374 RSUs were exercised.

 

·On October 31, 2026, a total of 4,444 performance share units were canceled.

 

·On November 1, 2026, a total of 944 stock options expired without being exercised.

 

·Subsequent to September 30, 2026, a total of 8,056 stock options were forfeited.

 

·Subsequent to September 30, 2026, a total of 5,000 RSUs were forfeited.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 24

 

 

11.Financial Instruments

 

As of September 30, 2026, the Company’s financial instruments comprise cash, trade receivables, accounts payable and accrued liabilities, lease liabilities and derivative warrant liabilities. The fair values of the Company’s financial instruments, other than the derivative warrant liability, approximate their carrying values due to their short-term maturity or applicable market interest rates. Derivative warrant liabilities are measured at fair value at each reporting date as disclosed on Note 15 to the condensed interim consolidated financial statements.

 

The Company’s financial instruments are exposed to certain financial risks including, credit risk, liquidity risk, foreign currency risks, equity price risk and capital risk management. Details of each risk are laid out in the notes to the Company’s condensed interim consolidated financial statements as at September 30, 2026. Details of each risk are summarized below:

 

a)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. To mitigate this risk, the Company monitors its anticipated expenditures and financing requirements to determine the funds required to support its ongoing operations and capital expenditures.

 

The Company seeks to raise sufficient funds through equity offerings or debt financings to meet its operating requirements, after considering existing cash balances and potential proceeds from the exercise of share purchase warrants, and stock options. The Company's ability to obtain additional financing is subject to uncertainty, as discussed in Note 1. As at September 30, 2026, the Company had cash of $3,720,790 (December 31, 2025 – $319,294) and current liabilities of $2,986,985(December 31, 2025 – $8,616,300).

 

During the nine months ended September 30, 2026, the Company repaid all amounts outstanding under its commercial agreement with Viken Detection Corporation. As a result, the outstanding balance due to Viken was reduced to $nil as at September 30, 2026. Subsequent to the repayment, Viken terminated its security interest by filing a UCC-3 Termination Statement on June 11, 2026.

 

As at September 30, 2026, the amount due to Viken was $nil (December 31, 2025 - $603,379). The Company also repaid the outstanding Parabilis term loan and credit line balances during the nine months ended September 30, 2026. As at September 30, 2026, the amount due to Parabilis was $nil (December 31, 2025 - $3,402,548). Refer to Notes 10 and 11(a) to the condensed interim consolidated financial statements for further details.

 

b)Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, including accounts receivable terms. The Company’s cash is held through large Canadian, international, and foreign national financial institutions. The Company’s receivables primarily consist of GST receivable due from the Canadian government and trade receivables that the Company continues to collect. These trade receivables are primarily with continuing customers and are not subject to significant credit risk. As at September 30, 2026, the Company’s trade receivables totalling $720,710 are from four customers (December 31, 2025 - $470,263). The Company’s maximum exposure to credit risk is limited to the carrying amount of cash and accounts receivables. The Company monitors the collectability of these receivables and assesses credit risk based on customer-specific circumstances.

 

c)Market risk

 

Market risk is the risk of loss that may arise from changes in market factors such as interest rates and foreign exchange rates.

 

Interest rate risk

 

Interest rate risk arises from changes in market rates of interest that could adversely affect the Company. During the nine months ended September 30, 2026, the Company repaid its outstanding term loan and credit line balances. As at September 30, 2026, the Company had no outstanding interest-bearing financial instruments, other than lease liabilities. Accordingly, the Company’s exposure to interest rate risk associated with borrowings was limited as at the reporting date.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 25

 

 

Foreign currency risk

 

The Company is exposed to currency risk by having balances and transactions in currencies that are different from its functional currency. The Company operates in foreign jurisdictions, which uses the U.S. dollar. The Company does not use derivative instruments to reduce upward, and downward risk associated with foreign currency fluctuations. The Company’s exposure to foreign currency risk is minimal.

 

Price risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company's earnings due to movements in individual equity prices or general movements in the level of the stock market.

 

As at September 30, 2026, the Company's exposure to equity price risk includes its derivative warrant liability, which is measured at fair value at each reporting date. Changes in the Company's share price and other valuation assumptions may result in gains or losses recognized in profit or loss.

 

The Company closely monitors movements in its share price and relevant market conditions to assess its exposure to equity price risk.

 

Capital Risk Management

 

The Company manages its capital structure, including, common shares, stock options, performance share units, restricted share units, share purchase warrants and debt financing, as applicable. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern, support the development and commercialization of its products, and maintain a flexible capital structure that optimizes the cost of capital at an acceptable level of risk.

 

The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may issue new shares, obtain debt financing, acquire or dispose of assets, or adjust its cash expenditures.

 

The Company monitors its capital requirements through ongoing assessments of anticipated operating expenditures, capital expenditures and available financial resources.

 

To support its ongoing development and commercialization activities, the Company does not currently pay dividends. The Company generally maintains its cash balances with established financial institutions.

 

The Company's ability to fund its ongoing operations and product development plans is dependent on obtaining additional financing, as discussed in Note 1 to the condensed interim consolidated financial statements. The Company is not subject to externally imposed capital requirements.

 

There has been no change to the Company’s approach to capital management during the nine months ended September 30, 2026.

 

12.Other requirements

 

Outstanding common share data:

 

Authorized: Unlimited number of common shares

 

Number of common shares issued and outstanding as at September 30, 2026: 5,681,983

 

Number of common shares issued and outstanding as at November 13, 2026: 5,683,357

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 26

 

  

Number of stock options outstanding and exercisable as at November 13, 2026, is as follows:

 

   Outstanding   Exercisable 
Expiry date  Number of stock
options
   Exercise price   Remaining
contractual life
(years)
   Number of stock
options
 
14-Jan-27   222   CAD$162.00    0.17    222 
15-Apr-27   1,111   CAD $26.55    0.42    1,111 
26-Apr-27   2,633   CAD$184.50    0.45    2,633 
2-Jul-27   5,556   CAD$10.80    0.64    5,556 
21-Nov-27   133   CAD$99.00    1.02    133 
26-Apr-28   111   CAD $81.00    1.45    111 
16-Oct-28   1,778   CAD $85.50    1.93    1,778 
30-Dec-29   46,390   CAD $38.25    3.13    37,112 
2-Apr-30   3,333   CAD $37.80    3.39    2,222 
30-Sep-30   38,332   CAD $12.15    3.88    38,332 
November 13, 2026   99,599              89,210 

 

Number of share purchase warrants as at November 13, 2026, is as follows:

 

   Warrants   Exercise 
   outstanding   Price 
Outstanding, December 31, 2024   446,109   CAD$54.90 
Issued   683,234    19.32 
Expired   (169,855)   32.79 
Exercised   (240,718)   20.27 
Outstanding December 31, 2025   718,770   CAD$36.45 
Issued   92,672    64.49 
Expired   (340,121)   15.75 
Outstanding September 30, 2026   471,321   CAD$47.76 
Expired   (40,966)   133.52 
Outstanding November 13, 2026   430,355   CAD$39.59 

 

Number of restricted share units as at November 13, 2026, is as follows:

 

   Number of
equity settled
RSUs
   Grant Price 
Outstanding, December 31, 2024   11,918   CAD$180.45 
Granted   8,260    10.91 
Exercised   (4,758)   115.88 
Outstanding December 31, 2025   15,420   CAD$55.51 
Exercised   (736)   113.13 
Cancelled   (1,672)   178.89 
Granted   318,888    2.97 
Outstanding, September 30, 2026   331,900   CAD$4.28 
Exercised   (1,374)   115.76 
Cancelled   (5,000)   2.96 
Outstanding, November 13, 2026   325,526   CAD$3.83 

 

Number of performance share deposited and held in escrow as at November 13, 2026:

 

   Number of
equity settled
performance
   Weighted average
price
 
Outstanding, December 31, 2024 and 2025   4,444    180.00 
Outstanding, September 30, 2026   4,444   CAD$180.00 
Forfeited   (4,444)   180.00 
Outstanding, November 13, 2026   -   CAD$nil 

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 27

 

 

13.Disclosure Controls and Procedures and Internal Controls over Financial Reporting

 

Disclosure controls and procedures are intended to provide reasonable assurance that information required to be disclosed is recorded, processed, summarized, and reported within the time periods specified by securities regulations and that the information required to be disclosed is accumulated and communicated to management. Internal controls over financial reporting are intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS. In connection with National Instrument 52-109 (Certificate of Disclosure in Issuer’s Annual and Interim Filings) (“NI 52-109”), the Chief Executive Officer and Chief Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect to the financial information contained in the condensed consolidated interim financial statements for the three and nine months ended September 30, 2026, and 2025, and this accompanying MD&A (together, the “Interim Filings”).

 

In contrast to the full certificate under NI 52-109, the Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting, as defined in NI 52-109. For further information, the reader should refer to the Venture Issuer Basic Certificates filed by the Company on SEDAR+ at www.sedarplus.ca.

 

The Company's Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") are responsible for establishing and maintaining disclosure controls and procedures ("DC&P") designed to provide reasonable assurance that material information relating to the Company is communicated to management and that information required to be disclosed under applicable securities legislation is recorded, processed, summarized and reported within the prescribed time periods.

 

Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining internal control over financial reporting ("ICFR") designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS Accounting Standards.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Company's ICFR during the three months ended September 30, 2026, that materially affected, or were reasonably likely to materially affect, the Company's ICFR.

 

Q3-2026 MD&A
(Expressed in U.S. dollars)

Page| 28

 

 

Exhibit 99.3

 

Form 52-109F2

Certification of Interim Filings

Full Certificate

 

I, Keith Teichmann, Interim Chief Executive Officer of Liberty Defense Holdings, Ltd., certify the following:

 

1.Review: I have reviewed the interim financial report and interim management discussion and analysis (“MD&A”) (together, the “interim filings”) of Liberty Defense Holdings Ltd. (the “issuer”) for the interim period ended September 30, 2026.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4.Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

 

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

(i)material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii)information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

5.2ICFR – material weakness relating to design: N/A

 

5.3Limitation on scope of design: N/A

 

6.Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2026, and ended on September 30, 2026, that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.

 

Date: 13th day of November, 2026

 

/s/ Keith Teichmann  
Keith Teichmann  
Interim Chief Executive Officer  

 

 

 

 

Exhibit 99.4

 

Form 52-109F2

Certification of Interim Filings

Full Certificate

 

I, Omar Garcia Abrego, Chief Financial Officer of Liberty Defense Holdings, Ltd., certify the following:

 

1.Review: I have reviewed the interim financial report and interim management discussion and analysis (“MD&A”) (together, the “interim filings”) of Liberty Defense Holdings Ltd. (the “issuer”) for the interim period ended September 30, 2026.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4.Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

 

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

(i)material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii)information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

5.2ICFR – material weakness relating to design: N/A

 

5.3Limitation on scope of design: N/A

 

6.Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2026, and ended on September 30, 2026, that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.

 

Date: 13th day of November, 2026

 

/s/ Omar Garcia Abrego  
Omar Garcia Abrego  
Chief Financial Officer  

 

2

 

Filing Exhibits & Attachments

4 documents

Keep reading